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1 Zusammenfassung Vor knapp 20 Jahren wurde Fettgewebe als Reservoir adulter mesenchymaler Stammzellen identifiziert. Während die therapeutische Anwendung der Zellen in der Praxis Realität ist, ist die Grundlagenerforschung noch lange nicht abgeschlossen. Erstes Ziel der vorliegenden Arbeit war es, zu charakterisieren, wie viele adulte Stammzellen in humanem Fettgewebe enthalten sind, das mit Wasserstrahl-assistierter Liposuktion gewonnen wurde. An Hand der erzielten Daten konnte quantitativ nachgewiesen werden, dass das so gewonnene Gewebe eine valide Quelle für die Gewinnung adulter mesenchymaler Stammzellen mit hoher Viabilität und mesenchymalem Differenzierungspotential ist.  Jeder einzelne Zelltyp im humanen Fettgewebe, erfüllt Aufgaben, die der Erhaltung der physiologischen Homöostase im Gewebe dienen und verfügt über einen Stoffwechsel, der je nach Funktion und Bedarf verändert werden kann. Ist der zelluläre Stoffwechsel gestört, kann das Defekte in der Verrichtung der zelltypspezifischen Aufgaben hervorrufen. Um solche Defekte im zellulären Stoffwechsel zu erkennen oder einzuordnen, muss zunächst der Metabolismus nativer Zellen beschrieben werden. Es war daher das nächste Ziel der Studie den energie-metabolischen Phänotyp zweier distinkter nativer Zellpopulationen des humanen Fettgewebes zu charakterisieren. Untersucht wurden adulte Adipozyten und die CD34+-Zellpopulation der stromalen vaskulären Fraktion desselben Gewebes. In ersten Charakterisierungen konnte zunächst gezeigt werden, dass die CD34+ Zellpopulation der stromalen vaskulären Fraktion mit mesenchymalen Progenitorzellen angereichert ist. Aktuelle Literatur liefert Hinweise darauf, dass Progenitorzellen ein höheres Potential für Proliferation und Differenzierung zeigen, als adulte Adipozyten. Bei beiden Zellpopulationen wurden dann die maximalen Enzymaktivitäten (=Enzymkapazitäten) verschiedener Markerenzyme wesentlicher Wege des Energiestoffwechsels quantifiziert und verglichen. Bei Markerenzymen handelt es sich um Enzyme, die irreversible oder Geschwindigkeits-limitierende Reaktionen verschiedener Stoffwechselwege katalysieren. Sie dienen so als Indikatoren für die Gesamtaktivität des jeweiligen Stoffwechselweges. Die untersuchten Adipozyten zeigten höhere Kapazitäten der Markerenzyme des Tricarbonsäurezyklus und der ß-Oxidation verglichen mit den CD34+ Zellen der stromalen vaskulären Fraktion. Dies deutet auf eine höhere mitochondriale Stoffwechselaktivität hin. Die CD34+ Zellen der 
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stromalen vaskulären Fraktion zeigten verglichen mit den Adipozyten höhere Kapazitäten der Markerenzyme von Glykolyse und Pentosephosphatweg, was Hinweise auf eine höhere Aktivität des zytosolischen Kohlenhydratstoffwechsels gibt. Es ist zu vermuten, dass Adipozyten so einen kontrollierten Lipidumsatz gewährleisten, während die CD34+ Zellen der stromalen vaskulären Fraktion ihre Versorgung mit Pentosen und Reduktionsäquivalenten für die Replikation von DNA und anderen Makromolekülen für die Proliferation absichern. Die gewonnenen Daten zeigen, dass die zwei untersuchten Zellpopulationen des humanen Fettgewebes sich in der grundlegenden Strukturierung ihres Energiestoffwechsels unterscheiden. Dies könnte eine Anpassung an ihre jeweiligen physiologischen Funktionen und Gegebenheiten in vivo sein. Zwei distinkte, native Zellpopulationen des menschlichen Fettgewebes mit unterschiedlichem Potential zu differenzieren und zu proliferieren, zeigen eine unterschiedliche Strukturierung ihres Stoffwechsels. Beim Übergang von Zellen aus einem nativen in ein in vitro Umfeld, wie es in Zellkulturmodellen der Fall ist, kommt es zu phänotypischen Veränderungen der Zellen. Werden die Zellen mit zusätzlichen Substanzen zur Differenzierung angeregt, finden weitere, ausgeprägtere Veränderungen in Phänotyp und Verhalten der Zellen statt. Die Beobachtung solcher Veränderungen in etablierten Modellen der osteogenen und adipogenen Differenzierung isolierter mesenchymaler Stammzellen des Fettgewebes führten zu der Frage, ob es auch in der Strukturierung des Energiestoffwechsels zu Änderungen kommt. Um dies zu untersuchen wurden die Zellen ohne und mit osteogener und adipogener Differenzierungsstimulation kultiviert. Proliferations- und Differenzierungsstatus der Zellen wurden quantifiziert und die Aktivitäten wesentlicher Wege des Energiestoffwechsels der Zellen wurden anhand von Aktivitätsbestimmungen bzw. RNA-Quantifizierungen von Markerenzymen erfasst. So konnten wir in nicht-differenzierenden und osteogen differenzierenden Zellen Proliferation nachweisen. Diese ging einher mit erhöhten Aktivitäten der Markerenzyme von Glykolyse und Pentosephosphatweg. Adipogen differenzierende Zellen, die nicht proliferierten, zeigten verminderte glykolytische Aktivität aber zur gleichen Zeit ebenso einen Anstieg ihrer mitochondrialen Enzymaktivitäten. Das gemeinsame Auftreten von metabolischer Umstrukturierung und Proliferationsverhalten der Zellen zeigten sich in ähnlicher Weise, wie es zuvor in den nativen Zellpopulationen des Fettgewebes beobachtet worden war. Die Veränderungen der Strukturierung des zellulären Energiestoffwechsels 
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können Anpassungen an den erhöhten Energiebedarf während der Proliferation repräsentieren sowie an spezifische zelluläre Funktionen, die sich während der osteogenen und adipogenen Differenzierung entwickeln. Mit der vorliegenden Arbeit konnten wir zur grundsätzlichen Charakterisierung des Energiestoffwechsels unterschiedlicher Zelltypen des menschlichen Fettgewebes im nativen Zustand sowie unter in vitro Bedingungen beitragen. Diese Arbeiten dienen als Grundlage weitergehender Untersuchungen des zellulären Energiestoffwechsel in klinischen sowie in Laborfragestellungen.  
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2 Summary Just under 20 years ago adipose tissue has been identified as a source of adult mesenchymal stem cells. While these regenerative cells are already being clinically applied, basic research and the fundamental characterization of the cells is ongoing. The first aim of the presented work was to quantify and characterize the content of adult mesenchymal stem cells within adipose tissue harvested with water-jet assistance. From our collected data we can conclude that adipose tissue harvested with water-jet assistance is a valid source for the isolation of adult mesenchymal stem cells with high viability and mesenchymal differentiation potential. Each of the cell types in adipose tissue, fulfills different tasks ensuring the physiological homeostasis within the tissue and possesses a metabolism that can be adapted to meet demands for diverging functions and needs. Defects of that cellular metabolism can lead to malfunctions of the cells that may prevent the execution of their essential tasks. In order to identify such defects, the cellular metabolism of native cells must be thoroughly described. It was thus the second aim of this study to characterize the energy metabolic phenotype of two distinct cell populations of the adipose tissue. We thus examined native adult adipocytes and CD34+ cells of the stromal vascular fraction, separated from the same tissue. In first characterization steps we could show that CD34+ cells of the stromal vascular fraction are a population enriched in adipose tissue-derived mesenchymal progenitors. Current literature indicates, that these kinds of progenitor cell types display a higher potential for proliferation and differentiation than adult adipocytes. For both cell populations, the maximum enzyme activities (=enzyme capacities) of marker enzymes of major energy metabolic pathways were quantified and compared. Marker enzymes are enzymes that catalyze irreversible or rate-limiting steps of different metabolic pathways. They thus serve as indicators for the overall activity of their respective pathways. Compared to the CD34+ cells of the stromal vascular fraction the examined adipocytes showed higher capacities of the marker enzymes of the tricarbolic acid cycle and the ß-oxidation. This indicates significantly higher metabolic activity of the mitochondria. The CD34+ cells of the stromal vascular fraction showed higher capacities of the marker enzymes of glycolysis and the pentose phosphate pathway, which suggests a higher activity of the cytosolic carbohydrate metabolism. This way the adipocytes may facilitate a controlled lipid turnover, while the 
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CD34+ cells of the stromal vascular fraction may ensure the provision of pentose phosphates and reduction equivalents for the replication of DNA and other macromolecules during potential proliferation. The data indicate that these two cell fractions of the human adipose tissue differ in their metabolic configuration. This might represent adaptations to their physiological tasks and demands in vivo.  We had observed the substantial differences in the energy metabolic configuration of two distinct cell populations of adipose tissue and their divergent potential to differentiate and proliferate. The transition of adipose-derived progenitors from their in vivo to an in vitro environment leads to significant phenotypic changes. An additional stimulation of the cells to differentiate leads to even more pronounced changes in the cell’s phenotype and behavior. These changes observed in established cell culture models of osteogenic and adipogenic differentiation lead to the question, if cultivation of adipose tissue-derived mesenchymal stem cells with osteogenic and adipogenic differentiation stimuli would also cause adaptations in the cell’s energy metabolic structure. For that we cultured adMSC with and without differentiation stimulation. The proliferation and differentiation status of the cells was quantified, and major energy metabolic pathways were analyzed with respect to their activity and gene expression. We could show that cells in non-differentiating and osteogenic cultivation conditions displayed active proliferation and showed increasing activities of the marker enzymes of glycolysis and the pentose phosphate pathway. Adipogenically differentiating cells, that did not proliferate, showed a reduced glycolytic capacity and increased mitochondrial marker enzyme activities at the same time. Thus, we could observe a similar connection between the energy metabolic configuration and the proliferation potential as we did before in the two native cell populations of the adipose tissue. These changes in energy metabolism might represent an adaptation of adMSC to the high energy demand during proliferation and to the specific cellular functions during osteogenic or adipogenic differentiation respectively. With the present work we were able to contribute to the characterization of the energy metabolism of distinct cell types of the human adipose tissue in the native state and after in vitro culturing. We were thus able to add to the groundwork needed for further examinations of the cellular metabolism of human adipose tissue in the clinical as well as the laboratory setting.  
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3 Introduction 
 Adipose tissue 
The adipose tissue of the human body is a multi-depot organ consisting of subcutaneous and visceral depots. For a long time, adipose tissue has been regarded as an organ of mere energy storage. Today its role as an endocrine organ that participates in the regulation of the metabolism, blood pressure, vascular homeostasis, bone metabolism and the immune system has generally been recognized (reviewed in (Trayhurn, 2005; Ferris and Crowther, 2011)). Adipose tissue is composed of a variety of cell types. Two major groups can be classified: adipocytes and stromal vascular cells, the latter being a heterogeneous cell population consisting of all cell types of the adipose tissue except the mature adipocytes. In the recent past the potential of adipose tissue in regenerative medicine has been discovered and studied. While the tissue itself is being used in clinical applications (reviewed in (Hsu et al., 2012)), it has furthermore been identified as a source of multipotent adult stem cells (Zuk et al., 2001; Zuk, 2010). 
3.1.1 Adipocytes Adipocytes can be classified as white, brite/beige and brown adipocytes. They differ regarding specific energy metabolic characteristics. White adipocytes store and release energy by turning over lipids (Strawford et al., 2004; Spalding et al., 2008), whereas brite/beige and brown adipocytes rather release energy in the form of heat through the uncoupling of oxidative phosphorylation from adenosine triphosphate (ATP) production (Cannon and Nedergaard, 2004; Hyvönen and Spalding, 2014). The main portion of adipose tissue is comprised of white adipocytes (Cypess et al., 2009). White adipocytes are unilocular, meaning they possess one big lipid vacuole for the accumulation of fatty acids. Their size may vary from 25 to 200 µm (Trujillo and Scherer, 2006). The size and number of white adipocytes in the tissue depend on the energy balance and are highly variable. Quantifications of the adipocyte content of adipose tissue range from 15 % to 80 % (Van Harmelen et al., 2003; Eto et al., 2009). A surplus of energy intake initially leads to a growth of the cells, called hypertrophy. When adipocytes have grown to their maximum size, they increase in number. This is called hyperplasia (Hausman et al., 2001). Amongst other factors white adipocytes can release the hormone leptin that regulates the body mass by influencing the individual food 
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intake (reviewed in (Ailhaud, 2006)). Brown adipocytes have been found in several depots of the human body but not in all adult humans brown adipose tissue can be identified and the brown adipocyte content appears to decrease depending on the individual’s age and body mass index (BMI) (Cypess et al., 2009; Saito et al., 2009; Zingaretti et al., 2009; Sacks and Symonds, 2013). In contrast to white adipocytes, brown adipocytes accumulate fatty acids in smaller, multilocular vacuoles and contain more mitochondria. The most distinct feature setting brown adipocytes apart from any other cell type is the expression of the uncoupling protein 1 (UCP1). UCP1 uncouples the proton gradient produced by oxidative phosphorylation from the ATP-production (reviewed in (Rosen and Spiegelman, 2006)). 
3.1.2 Stromal vascular fraction All cells of the so-called stromal vascular fraction (SVF) can be conjointly collected during the process of enzymatic dissociation and centrifugation of the adipose tissue. Cell types of the SVF that could be identified so far include nucleated cells like blood and blood derived cells, endothelial cells, smooth muscle cells, macrophages, pericytes, fibroblasts, hematopoietic progenitor cells and mesenchymal stem/stromal cells as well as non-nucleated cells, erythrocytes (Furness and McNagny, 2006; Zimmerlin et al., 2010; Tallone et al., 2011; Sidney et al., 2014). The composition of the SVF underlies a substantial patient to patient variability. It depends on the vascularization of the tissue and methodical aspects like the technique used for adipose tissue harvest, SVF extraction procedure and the applied analyses methods ((Patrick, 2000; Bourin et al., 2013)). Most characterizations of the cell type composition of the SVF are done via surface marker expression analysis in flow cytometry. To this day most research groups use different panels of surface markers. Furthermore, the time points, when the cells are subjected to analyses, differ. Some groups use freshly isolated cells, others examine cells that have been in an in vitro cell culture environment for several passages. Thus, at this point no conclusive statement can be made on the quantity distribution of the different cell types in the SVF. In animal studies the SVF has shown the ability to promote the assembly of vascular networks (Koh et al., 2011; Nunes et al., 2013).  
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3.1.2.1 Adipose tissue-derived stem/stromal cells Adipose tissue-derived mesenchymal stem/stromal cells (adMSC) are the type of mesenchymal stem/stromal cell (MSC) that is resident in adipose tissue.  Friedenstein and colleagues were the first to mention MSC as marrow stromal stem cells (Friedenstein, Piatetzky-Shapiro and Petrakova, 1966). They defined the cells to be adherent to tissue culture plastic, clonogenic, nonphagocytic and with a fibroblastic phenotype. Since then many efforts have been made to find and define their exact in vivo localization and function. One reasonable model that has been suggested is a perivascular association of MSC where they stabilize the vasculature and contribute to the homeostasis of the surrounding tissue and the immune system. This model also makes sense regarding the fact, that MSC have not only been found in bone marrow (Friedenstein, Piatetzky-Shapiro and Petrakova, 1966) but in essentially all organs (da Silva Meirelles, 2006). They have been isolated from adipose tissue, periosteum, tendon, periodontal ligament, muscle, synovial membrane, spleen, kidney, lung, aorta, vena cava, brain, thymus, skin and lungs ((da Silva Meirelles, 2006) and reviewed in (da Silva Meirelles, Caplan and Nardi, 2008)). Based on the available data the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy (ISCT) has drafted minimal criteria to define human MSC (Dominici et al., 2006). The cells must be plastic adherent under standard culture conditions, and they must be able to differentiate into osteoblasts, adipocytes and chondroblasts in vitro when stimulated accordingly. Third they must be positive for cluster of differentiation 105 (CD105), CD73, and CD90 and negative for CD45, CD34, CD14 or CD11b, CD79a or CD19, and HLA-DR. The CD nomenclature is widely adopted by the scientific community and is officially approved by the International Union of Immunological Societies and approved by the World Health Organization (Engel et al., 2015). The identification of a CD antigen or a group of CD antigens on a cell surface is used for the characterization of cell types, as CD molecules may be specific for one cell or cell lineage (Actor, 2014). The authors acknowledge the need to amend and correct the proposed definitions with the progressing data base on MSC. The in vitro differentiation potential of MSC is versatile. Besides the mesenchymal lineages like osteoblasts, adipocytes, myocytes and chondrocytes, the cells were found to 
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differentiate into endothelial cells, hepatocytes, smooth muscle cells, neurogenic cells and epithelial cells (Planat-Benard et al., 2004; Rodriguez et al., 2006; Sotiropoulou et 
al., 2006; Banas et al., 2007; Pǎunescu et al., 2007; de la Garza-Rodea et al., 2012). As these are all phenomena observed in in vitro environments, the trans-differentiation potential of MSC in vivo remains in question. The minimal criteria identifying MSC postulated by the Mesenchymal and Tissue Stem Cell Committee of the ISCT in 2006 have been adjusted and refined for the definition of adMSC by the International Federation for Adipose Therapeutics and Science (IFATS) together with the ISCT in 2013 (Bourin et al., 2013). According to their definition adMSC that are plastic adherent are positive for the surface markers CD90, CD73, CD105, and CD44 and negative for CD45 and CD31 and also possess adipogenic, osteogenic and chondrogenic differentiation potential. One of the most important aspects, that has been added to the criteria is that before submission into tissue culture plastic the cells are also positive for CD34. CD34 was first identified in stromal progenitor cells in adult bone marrow from humans (Simmons and Torok-Storb, 1991). The Stro-1 antibody, frequently used for the isolation of MSC, was subsequently generated using CD34-positive MSC (Simmons and Torok-storb, 1991). CD34 was then found to be expressed also by activated hematopoietic stem cells cycling in the blood stream. Hematopoietic stem cells in a quiescent state reside in the bone marrow and have been found to be CD34 negative (Lin et al., 2013). The panel of CD34-expressing cells was later extended to muscle satellite cells, interstitial cells, epithelial, and endothelial precursors (reviewed in (Sidney et al., 2014)). CD34 is currently thought to be expressed by all perivascular cells in situ (Crisan et al., 2012). According to existing literature, approximately 60–85 % of the CD34+ cells of the stromal vascular fraction (CD34+ SVF-cells) are adMSC (Lin et al., 2008; Eto et al., 2009; Zimmerlin et al., 2013; Feisst et al., 2014; Klar et al., 2016). It has been proposed that CD34 promotes proliferation and migration and blocks differentiation in vivo (Krause et al., 1996; Nielsen and Mcnagny, 2008). This might be substantiated by the general observation, that CD34-expression decreases with increasing culture time, when the cells in fact do proliferate, migrate and differentiate (Mitchell et al., 2006; Kaiser et al., 2007) .  Compared to bone marrow adipose tissue can be harvested in large quantities in minimally invasive procedures. These procedures are also associated with fewer 
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discomfort and donor site morbidity for patients (Man and Meyer, 2007). immunomodulatory capacity has been demonstrated in bmMSC and adMSC (Melief et al., 2013). In vivo the immunosuppressive function of MSC is thought to be essential for a balanced immune response and the prevention of autoimmunity (reviewed in (da Silva Meirelles, Caplan and Nardi, 2008)). 
 Adipose tissue and derived cells in the clinic 
Adipose tissue as well as isolated cellular components are clinically applied for regenerative therapy approaches. Adipose tissue has been used to treat for example carpometa-carpal joint osteoarthritis, wound healing deficits and radiation damage (Rigotti et al., 2007; Stasch et al., 2015; Herold et al., 2017). The SVF separated from adipose tissue has also been applied in the clinical setting for a wide variety of indications. They have been applied to treat ischemic cardiomyopathy, urinary incontinence, osteoarthritis, chronic ulcers, enterocutaneous fistula, systemic sclerosis (Marino et al., 2013; Gotoh et al., 2014; Perin et al., 2014; Guillaume-Jugnot et al., 2015; Michalek et al., 2015; Mizushima et al., 2015). Also adMSC have been isolated and cultured prior to their clinical application. In the course of some studies the influence of adMSC on multiple sclerosis, graft versus host disease and osteoarthritis (Fang et al., 2007; D. et al., 2010; Pers et al., 2016) was examined with promising results. In case studies, human adMSC were also successfully used to treat critical-size calvaria and maxilla defects (Lendeckel et al., 2004; Mesimäki et al., 2009). 
 Energy metabolic analyses of cells and tissues  
3.3.1 Rational of determining the energy metabolic phenotype by enzyme 
activity measurements Changes in metabolism can be caused by and also be dependent on cell fates such as proliferation, differentiation or apoptosis (reviewed in (Ochocki and Simon, 2013; Shyh-Chang and Daley, 2015)). The demands on energy supply of different cell types vary dependent on their function and environment (reviewed in (Lonergan, Bavister and Brenner, 2007; Vander Heiden, Cantley and Thompson, 2009)). Short-term changes in energy demand that require adaptation within seconds (e.g. in the active muscle), can be realized by modifications of regulatory enzymes that will lead to increases or decreases 
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of activity. These modifications can be of non-covalent (allosteric regulation) or of covalent nature (e. g. phosphorylation). Changes of enzyme concentrations are rather an indication of long term adaptations of energy metabolism to specific environments or cell functions (Nelson and Cox, 2011). Enzyme activities measured in vitro under standard optimal conditions are designated as international units per mg DNA (1 U=1 
μmol substrate transformed per min at 37 °C). Thus, in vitro measured maximum activities represent a capacity of metabolic turnover and not the turnover in vivo in a specific metabolic state. However, the maximum activities of enzymes which catalyze irreversible or flux-limiting reactions of different metabolic pathways serve as indicators of the participation of these pathways in energy metabolism, as previous studies have shown a good correlation of the capacities of energy metabolic pathway marker enzymes with their contribution to the energy metabolism (Newsholme and Start, 1977). This is the case for enzymes that catalyze reactions far away from the equilibrium (called non-equilibrium reactions), that will show enzyme activities close to the actual activities in vivo. In contrast, enzymes working near the thermodynamic equilibrium of the reaction (called near-equilibrium reactions), will likely show lower activities in vivo than measured in vitro (Pette, 1970). 
3.3.2 Analyzed enzymes of the cellular energy metabolism Metabolism accomplishes four essential functions for cells. It breaks down complex nutrients into simpler molecules and generates energy (i.e. catabolism). It builds up macromolecules from simpler molecules which consumes energy (i.e. anabolism). It provides energy in the form of ATP in order to facilitate cellular functions, for example the transportation of molecules into and out of the cell. Finally, many metabolites from various pathways also play a role in cellular signaling and gene transcription (Chandel, 2015). The presented studies focus on catabolic processes leading to the provision of energy as well as anabolic processes utilizing cellular energy in the form of ATP. Glycolysis is the initial step in the metabolic breakdown of glucose. During glycolysis one molecule of glucose is broken down in to two molecules of pyruvate. Two molecules of ATP and nicotinamide adenine dinucleotide anion (NADH) are produced respectively. This takes place in the cytosol and does not require oxygen. The 
phosphofructokinase (PFK; EC 2.7.1.11) catalyzes the second of the three irreversible 
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reactions of glycolysis (Chandel, 2015), the conversion of fructose-6-phosphate and ATP to fructose-1,6-bisphosphate and adenosine diphosphate (ADP). It is thus one of the essential, rate limiting steps of glycolysis. The maximum PFK activity measured in vitro can be recognized as the capacity of glycolysis in vivo. The sixth step of glycolysis, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate, in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD+), is catalyzed by the glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) (Veech, Raijman and Krebs, 1970). The pyruvate molecules resulting from glycolysis can be used by the cells in different ways. If the oxygen supply of the cell is sufficient, the pyruvate is transported into the mitochondria where it is decarboxylated to acetyl coenzyme A (acetyl-CoA) and as such enters the tricarbolic acid cycle (TCC). The TCC has been identified to be amphibolic. Depending on the current supply of energy within the cell, intermediates of the TCC can be metabolized in a circulatory fashion producing the reduction equivalents NADH and flavin adenine dinucleotide hydroquinone (FADH2), which donate electrons to the electron transport chain, resulting in the formation of the proton gradient that is needed for ATP production. This would be the catabolic function of the TCC. If the cell is in need of building blocks for biosynthesis, the anabolic function of the TCC is primarily active. The intermediate α-ketoglutarate, for example, is produced by the irreversible (and thus rate limiting) oxidative decarboxylation of isocitrate, catalyzed by the NAD+-
dependent isocitrate dehydrogenase (NAD-IDH; EC 1.1.1.41) or the reversible oxidative decarboxylation of isocitrate, catalyzed by the NADP+-dependent isocitrate 
dehydrogenase (NADP-IDH; EC 1.1.1.42) (Henderson, 1965). It can be converted to glutamate, that can generate glutamine, a precursor for the synthesis of purine nucleotides (Chandel, 2015), building blocks of deoxyribonucleic acid (DNA).  In cells lacking physiologic oxygen supply for oxidative phosphorylation (Nelson and Cox, 2011), or in highly proliferative cells, a mechanism is activated in which lactate 
dehydrogenase (LDH; EC 1.1.1.27) reduces pyruvate into lactate under the conversion of NADH into NAD+ (Warburg, Wind and Negelein, 1927; Lunt and Vander Heiden, 2011). This way the production of lactate is coupled to the regeneration of NAD+ that can re-enter glycolysis, that may thus be kept active without the need for oxidative phosphorylation. If the need of the cells for energy and building blocks is saturated, 
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pyruvate can be converted into glucose via gluconeogenesis. In order to avoid a futile cycle, gluconeogenesis and glycolysis are tightly regulated pathways, that are reciprocally controlled. If one process is active, the other is not entirely shut down but strongly inhibited(Chandel, 2015). The pyruvate for gluconeogenesis will thus not be derived from glycolysis but from precursors like lactate, glycerin or some amino acids. Glycolysis and gluconeogenesis share the enzymes that control the reversible reaction steps. The three irreversible reactions of glycolysis are bypassed by alternative enzymes so gluconeogenesis can proceed (Nelson and Cox, 2011). While fructose-6-phosphate is converted to fructose-1,6-bisphosphate by PFK during glycolysis, the dephosphorylation of fructose-1,6-bisphosphate to fructose 6-phosphate is catalyzed by fructose-1,6-bis-
phosphatase (FBPase, EC 3.1.3.11) during gluconeogenesis. FBPase represents one of the rate limiting steps of gluconeogenesis.  The FBPase is also of major importance for the function of the pentose phosphate pathway (PPP). The PPP can be subdivided into an oxidative and a nonoxidative phase. In the nonoxidative phase, depending on the demand of the cell, carbohydrates with a different amount of carbon atoms can be converted into one another by transketolases and transaldolases. These can then be used as precursors for different anabolic pathways. Ribose-5-phosphate for example is needed for the synthesis of nucleotides (Chandel, 2015). During the oxidative phase of the PPP ribose-5-phosphate is oxidized, resulting in the formation of carbon dioxide, hydrogen ions and NADPH. The first step of the oxidative phase of the PPP, the oxidation of glucose-6-phosphate to 6-phosphoglucono-δ-lactone, is catalyzed by the glucose 6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49). The produced NADPH is on one hand required for the biosynthesis of fatty acids and isoprenoids; on the other hand, it is needed for the maintenance of the antioxidative activity of glutathione. Glutathione is a scavenger of reactive oxygen species (ROS) that are formed during oxidative phosphorylation in the mitochondria. During the neutralization of ROS, glutathione is oxidized and forms a dimer with another oxidized glutathione. For the restoration of its antioxidative properties the glutathione disulfide is reduced and converted back into two monomers by the glutathione disulfide reductase (GSR; EC 1.8.1.7). For this reaction the GSR uses the NADPH supplied by the G6PDH reaction. By measuring the GSR activity, the level of oxidative stress and thus the level of oxidative phosphorylation for ATP production in the mitochondria can be assessed indirectly. 
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If the glucose supply is low, fatty acids are the primary source of cellular energy. The catabolic breakdown of fatty acids is called β-oxidation. This pathway is located in the mitochondrial matrix, generates NADH and FADH2 and thus facilitates ATP production. The ß-hydroxyacyl-CoA dehydrogenase (HOADH; EC 1.1.1.35) catalyzes the third of four steps that are continuously repeated during the degradation of the fatty acid chain molecules (Wakil et al., 1954). In this step, β-hydroxyacyl-CoA is oxidized to 
β-ketoacyl-CoA while NAD+ is reduced to NADH. Following this step acetyl-CoA is released from the fatty acid molecule. Acetyl-CoA can then be transferred into the TCC. Finally, an enzyme known to be found in cells with temporarily high or fluctuating energy turnover like striated muscle or nervous tissue (Berlet, Bonsmann and Birringer, 1976; Wallimann and Hemmer, 1994b) was examined. The creatine 
kinase (CK; EC 2.7.3.2) catalyzes the near-equilibrium reaction of the conversion of creatine into phosphocreatine under the consumption of ATP (Lohmann, 1934). As this reaction is reversible, ATP can also be generated from phosphocreatine and ADP by the CK. The enzyme was first identified in the cytosol, but the finding of a mitochondrial isozyme led to the idea of a functional coupling of CK with oxidative phosphorylation, the so called phosphocreatine shuttle (Bessman, 1972; Saks et al., 1985; Wallimann and Hemmer, 1994b). In the mitochondria the synthesis of phosphocreatine is catalyzed by the mitochondrial CK with nascent ATP. It diffuses to the myofibrils. As during a contraction myosin-ATPases generate ADP, the muscular creatine kinase catalyzes the regeneration of ATP from phosphocreatine and ADP to allow the contraction to continue. Creatine is thus released from the myofibrils and diffuses back to the mitochondria where it is re-phosphorylated to creatine phosphate. The immediate return of ADP in the mitochon-dria, stimulates oxygen uptake (Bessman, 1972; Bessman and Carpenter, 1985). 
 Energy metabolism of adipose tissue and derived cell types 
3.4.1 Energy metabolism of adipose tissue First specimens of energy metabolic studies were homogenates of whole adipose tissue from living as well as deceased patients (Schmidt and Schmidt, 1960; Shonk et al., 1964; Schwandt et al., 1970). Due to the aforementioned variations in cellular composition of the adipose tissue these examinations of adipose tissue metabolism 
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cannot give a differentiated picture regarding the metabolic configuration of specific cell populations. Those limitations have been recognized and discussed. As such, varying blood contents of the specimens as well as post mortem enzyme activation and inactivation may cause major deviations in the spectrum of identified enzymes and measured enzyme activities (Schmidt and Schmidt, 1960). Early examinations have found low glycolytic enzyme activities compared to other tissues like skeletal muscle. The determined activities of glycolysis were comparable to measured activities of gluconeogenesis (Shonk et al., 1964; Schwandt et 
al., 1970). Moreover, it was uncovered, that the energy metabolic configuration strongly diverges between different mammalian species. As such activities measured in rat adipose tissue for example cannot automatically be conferred to another mammalian species. First examinations of the glucose metabolism of rat adipocytes and cells of the stromal vascular fraction separated from the same tissue were carried out in 1964 (Rodbell, 1964). It was suggested that the glucose metabolism of the whole adipose tissue was quantitatively made up by the measured adipocyte glucose metabolism. Stromal vascular cells did not take part in triglyceride synthesis. Recent studies compared the metabolism of adipocytes and stromal vascular cells from human tissue. Protein expression analysis implies that glycolysis and gluconeogenesis are upregulated in adipocytes compared to SVF-cells separated from the same tissue (Kheterpal et al., 2011). Ribonucleic acid (RNA)-expression analysis showed an upregulation of lipolysis related genes and GAPDH mRNA in adipocytes compared to SVF-cells (Fain et al., 2008). The presence and high activity of CK in white as well as brown adipocytes has been verified (Berlet, Bonsmann and Birringer, 1976; Wallimann and Hemmer, 1994a). In white adipocytes creatine could accept its phosphate group from cytoplasmic ATP generated during glycolytic substrate phosphorylation. It could also be synthesized in the mitochondria from nascent ATP produced during oxidative phosphorylation, as it was earlier described for the phosphocreatine shuttle (Bessman and Carpenter, 1985). 
3.4.2 Energy metabolism of adipose tissue-derived stem/stromal cells in vitro Based on the paucity of scientific knowledge on the energy metabolism of adMSC, conclusions can mainly be drawn from studies examining MSC. Studies concerning the 
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energy metabolism of MSC, typically describe bmMSC. In these studies, the metabolism is mainly characterized using the quantification of the uptake of nutrients and release of metabolites. Rather than using oxidative phosphorylation, bmMSC primarily metabolize glucose via aerobic glycolysis (Schop et al., 2009). Pattappa et. al. thus suspected the MSC to show the Warburg effect (Pattappa et al., 2011). The Warburg effect is defined as the utilization of glycolysis followed by lactate production as the major energy source despite sufficient oxygen being present for the cells to carry out oxidative phosphorylation (Warburg, 1956). This metabolic configuration had previously been shown mostly for cancer cells (Pelicano et al., 2006).  Osteogenically stimulated bmMSC as well as bmMSC without stimulation were found to produce ATP via a mixture of glycolysis as well as oxidative phosphorylation (Pattappa et al., 2011). By gene expression analysis, it was uncovered that the osteogenic differentiation of bmMSC leads to an increase of mitochondrial DNA copies. At the same time the intracellular amount of ATP and the activity of anti-oxidative enzymes increase, suggesting an increase of oxidative metabolism due to osteogenic differentiation (Chen et al., 2008). There are divergent findings on the development of oxygen uptake during osteogenic differentiation (Chen et al., 2008; Pattappa et al., 2011). While Chen et al. had documented an increasing rate of cellular oxygen consumption upon osteogenic stimulation of bmMSC, Pattapa et al. had observed similar rates of cellular oxygen consumption in bmMSC cultured without stimuli and following osteogenic stimulation. Adipogenic differentiation of bmMSC is described to be regulated by mitochondrial respiration (Zhang et al., 2013). In bmMSC undergoing early adipogenic differentiation antioxidative defense components become more oxidized, remaining in this state throughout the process. This suggests a regulation of differentiation by the redox state of the cell and thus assigns an essential role to antioxidative components like glutathione (Imhoff and Hansen, 2011). Adipogenic differentiation of adMSC is accompanied by an increase in the amount of mitochondrial as well as glycolytic and fatty acid metabolism associated proteins (DeLany et al., 2005).  
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 Working hypothesis and objectives 
The development of new possibilities for the therapeutic application of extracted adipose tissue have made the choice of the liposuction technique a vital issue. In this context not only aspects of patient comfort and donor site morbidity are of importance. Also, basic properties of the aspirated tissue like the cellular composition and viability need to be characterized. Water-jet assisted liposuction has proven to provide a favorable aesthetic outcome combined with lowered risk of cardiovascular side effects compared with conventional liposuction procedures (Man and Meyer, 2007; Stutz and Krahl, 2009; Stabile et al., 2014). Thus, in the first study we examined adipose tissue aspirated with water-jet assistance for the presence of adMSC possessing the characteristic properties defined for this cell type by the ISCT. Each of the cell types in adipose tissue, contributes to the physiological homeostasis of the tissue and possesses a metabolism that can be adapted to meet demands for diverging functions and needs. It is known, that different cell populations residing within adipose tissue show distinct behavior regarding proliferation and differentiation (Vander Heiden, Cantley and Thompson, 2009; Lunt and Vander Heiden, 2011). The intent of the second study was thus to compare maximum catalytic activities of major energy metabolic pathways of isolated mature adipocytes and CD34+ SVF-cells. After showing that differing proliferative potential of distinct cell populations from adipose tissue is accompanied by differing energy metabolic configurations, we hypothesized that the in vitro culture and differentiation of adMSC that is accompanied by changes in their proliferative behavior causes a diverging energy metabolic phenotype. Therefore, we analyzed major metabolic pathway activities in undifferentiated and differentiating adMSC in parallel with the cell numbers and degree of differentiation.  With these new data we would be able to contribute to the characterization of the energy metabolic phenotype of distinct cell populations of the human adipose tissue in the native state and after in vitro culturing with osteogenic and adipogenic differentiation.  
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4 Summary and discussion of the publications 
 Summary and discussion Study I - Isolation and differentiation 
potential of human mesenchymal stem cells from adipose tissue 
harvested by water jet-assisted liposuction 
As water jet-assisted lipoplasty is a favorable aspiration method regarding aesthetic outcome and patient comfort (Man and Meyer, 2007), it was necessary to assess the tissues suitability as a source of adMSC. Therefore, we examined the amount of isolatable SVF cells and the content of adMSC in the SVF. After isolation the proliferation and mesenchymal differentiation capacities of the cells were examined. This work was published in the Aesthetic Surgery Journal under the title “Isolation and differentiation potential of human mesenchymal stem cells from adipose tissue harvested by water jet-assisted liposuction”. By flow cytometric characterization we could show that from 1 ml of tissue on average 6.1 x 105 viable nucleated cells of the stromal vascular fraction may be isolated (Fig. 1). Different SVF cell numbers have been found after using different tissue harvesting methods. A study not selecting for a specific liposuction technique found an average of 3×105 isolatable SVF-cells per ml tissue (Mitchell et al., 2006). Another study found 6×105 SVF-cells per ml tissue after ultrasound-assisted liposuction and 7×105 SVF-cells per mL tissue after adipose tissue resection (Oedayrajsingh-Varma et al., 2006). Determined by magnetic bead selection we determined an average of 43 % of the viable plastic adherent SVF-cells to be CD34 positive. Examinations of other groups resulted in averages of 22.5 % (James et al., 2012) and 15 % to 40 % cells per ml tissue (Yoshimura et al., 2006). One portion of the CD34-positive cells is of hematopoietic origin while the other is adMSC. This was confirmed by Bourin et al. by detecting a CD34-positive, yet CD45-negative population of cells within the SVF of adipose tissue. Hematopoietic precursors would be positive for both surface markers (Bourin et al., 2013). The mesenchymal and hematopoietic populations could also be separated by selecting them for tissue culture polystyrene adherence because adMSC are plastic adherent (Rada, Reis and Gomes, 2011) whereas hematopoietic stem cells are not 
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(Glimm and Eaves, 1999; Handgretinger et al., 2002). While the adMSC content is often quantified solely by flow cytometric analysis of the SVF, in our study the absolute adMSC content was ultimately determined after 24 hours of plastic adherence. About 18 % of the viable SVF became adherent to tissue culture plastic. After 24 hours nearly 8 % of the initially isolated SVF could be identified as plastic-adherent and CD34-positive and thus representing a homogenous population of adMSC. Other groups have found 6.3 %±1.8 % to be functional adMSC residing in the SVF of resected adipose tissue, 1.9 %±1.3 % functional adMSC in the SVF of tissue obtained by tumescent liposuction, and 0.4 %±0.1 % functional adMSC in the SVF of tissue obtained by ultrasound-assisted liposuction (Oedayrajsingh-Varma et al., 2006).  
Fig. 1: Quantification of cell amount after each iso-lation step. 6.1x105 cells/g tissue in the SVF; 2.6x105 CD34+ cells/g tissue in the SVF; 0.8x105 cells/g tissue ad-herent after 24 h; 0.45x105 cells/g tissue adherent after 24 hand CD34+; data displayed as medians of 7 donors; measurements as technical duplicates; adapted from (Meyer et al., 2015) 
Fig. 2: Quantification of proliferation 
of adMSC under steady state standard cultivation. Cells show continuous proliferation over 35 d of cultivation. Data displayed as medians of 8 donors; measurements as technical triplicates; adapted from (Meyer et al., 2015)  With a range from 2.3 % to 17.9 %, broad deviations of adMSC content in the SVF are evident for our data. Such ranges have been obtained by others before. Philips et al. for example found the range of adMSC content in the SVF to range from 4 % to 37 % (Philips et al., 2013). The overall differences between the study outcomes result from differences between the aspiration methods and differences between the methods used for the analysis of adMSC content in adipose tissue. Measurements under steady state standard culturing conditions at 0, 7, 21 and 35 days, confirmed increasing cell numbers over time and thus the ability of the cells to proliferate (Fig. 2). The mesenchymal differentiation potential of the isolated adMSC was determined by cytochemical staining of specific markers of differentiation after culture with adipogenic and osteogenic stimulation. After 14 days of adipogenic stimulation, a 
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significant 3-fold increase of the formation of lipid-filled vacuoles in adMSC was detectable, whereas no vacuoles were found in adMSC under control conditions (Fig. 3). This proves the adipogenic differentiation potential of the adMSC from WAL tissue.  
   
Fig. 3: Adipogenic differentiation of adMSC. Staining of lipid vacuoles (green) and nuclei (blue) in unstimulated control cultures (A) and adipogenically stimulated adMSC (AS) after 14 days (B). Quantification of lipid content (C, quantification of fluorescence intensity; data displayed as medians of 5 donors; measurements as technical triplicates; *=significantly different; Mann-Whitney U Test, p < 0.05). Adapted from (Meyer et al., 2015)  
   
   
Fig. 4: Osteogenic differentiation of adMSC. ALP-staining (red) in control cultures (A) and in osteo-genically stimulated cultures (OS) after cultivation for 21 days (B). Quantification of ALP activity (C; data displayed as medians of 6 donors; *=significantly different; measurements as technical triplicates; Mann-Whitney U Test, p < 0.05). Staining of ECM calcium deposition in control cultures (D) and osteogenically induced cultures after cultivation for 35 days (E). Quantification of ECM calcium content (F, cresolphthalein staining; data displayed as medians of 4 donors; measurements as technical triplicates; *=significantly different; Mann-Whitney U Test, p < 0.05). Compared with non-stimulated control cultures, osteogenically stimulated cultures showed a 4-fold increase in ALP activity after 21 days and a 100-fold higher calcium deposition in the ECM after 35 days. Adapted from (Meyer et al., 2015)  The osteogenic differentiation potential was examined by the quantification of the activity of the enzyme bone-specific alkaline phosphatase (ALP) and the amount of calcium phosphate deposited to the extracellular matrix (ECM). After 21 days in culture osteogenically stimulated cells showed a 4-fold higher ALP-activity then the cells in 
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control cultures without specific stimulation. ECM calcium phosphate deposition by adMSC stimulated osteogenically for 35 days was almost 100-times higher than in the control cultures, which showed almost no calcium phosphate deposition (Fig. 5). We were thus able to verify the mesenchymal differentiation potential of adMSC from WAL tissue. 
 Summary and discussion Study II - Human adipocytes and CD34+ 
cells from the stromal vascular fraction of the same adipose tissue 
differ in their energy metabolic enzyme configuration 
Dependent on the developmental stage of the individual and the depot location, adipose tissue varies in cellular composition and metabolic phenotype. As the know-ledge about the energy metabolism of specific cell types of human adipose tissue is limited, we compared marker enzyme activities of major energy metabolic pathways of human adipocytes with those of the CD34+ SVF-cell population with enriched adMSC content (Lin et al., 2008; Eto et al., 2009; Zimmerlin et al., 2013; Feisst et al., 2014; Klar 
et al., 2016). This work was published in Experimental Cell Research under the title “Human adipocytes and CD34+ cells from the stromal vascular fraction of the same adipose tissue differ in their energy metabolic enzyme configuration”. For the separation of the two cell populations, human adipose tissue was subjected to enzymatic dissociation, generating a single-cell suspension. Via washing, filtration and centrifugation the lipid phase containing only adipocytes was separated from the aqueous phase that contained the SVF-cells. Through this procedure adipo-cytes, recognizable due to their monolocular vacuole and SVF-cells, characterized by diversity in morphology, were collected. A significant subpopulation of the SVF shows a surface expression of the transmembrane phosphoglycoprotein CD34 (Mitchell et al., 2006; Zimmerlin et al., 2010; Tallone et al., 2011; Bourin et al., 2013). Flow cytometry showed that 36.9 % of the total isolated SVF-cells were CD34+. Concurrent positivity for CD34 as well as for CD45 was detected for only 0.9 % of the SVF-cells. Thus, within the CD34+ SVF, 97.6 % of the cells were CD45-negative (CD45-). By means of a magnetic bead selection, the CD34+ cells were accumulated and separated (Fig. 5). The CD34+ SVF-cell population contains endothelial cells, endothelial progenitors, hematopoietic pro-genitors, adMSC and adipocyte progenitors (Furness and McNagny, 2006; Sidney et al., 
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2014). Other groups have found 13.3 % to 15.4 % of the adipose tissue SVF to be CD45-/CD34+ and CD31+. SVF-cells with this composition of surface markers are mature endo-thelial cells or endothelial progenitors (Eto et al., 2009; Zimmerlin et al., 2013). We found only 0.9 % of the nucleated SVF-cells to be hematopoietic precursors, that are CD34+/CD45+ (Tavian et al., 1996). In other studies, 2–4 % of SVF-cells were detected to be CD34+/CD45+ (Astori et al., 2007; Rose et al., 2015). Altogether 60–85 % of the SVF-cells collected with the described method of CD34-bead selection can be considered adMSC (Lin et al., 2008; Zimmerlin et al., 2013; Feisst et al., 2014; Klar et al., 2016). 
 
Fig. 5 I: Schematic depiction of the adipose tissue processing and II: Microscopic depiction of the 
tissue and cell fractions during processing. A) aspirated adipose tissue, (B) adipocytes from the lipid phase of the tissue preparation, (C) SVF after separation, (D) phase contrast micrograph of CD34+ SVF-cells with magnetic beads, (E) vital/nuclear stain of the CD34+ SVF-cells from the SVF with magnetic beads (green: vital stain, blue: nuclei, scale bar=100 μm in A and B; 50 μm in C, D and E). Adapted from (Meyer et al., 2019)  Mature adipocytes are considered to not proliferate but continuously turnover their stored lipids (Hausman et al., 2001; Strawford et al., 2004; Spalding et al., 2008). As the majority of the CD34+ SVF-cells possess a precursor status, they have the potential to proliferate and differentiate (Ogawa, 1993; Hausman et al., 2001; Zuk et al., 2002; Yoder, 
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2012). Adipocytes and CD34+ SVF-cells thus face distinct physiological requirements that might cause differences in their metabolic configuration. Activity of the glycolysis-related enzymes PFK (0.21 U/mg DNA in adipocytes; 0.95 U/mg DNA in CD34+ SVF-cells), GAPDH (10.8 U/mg DNA in adipocytes; 6.37 U/mg DNA in CD34+ SVF-cells) and LDH (25.3 U/mg DNA in adipocytes; 11.1 U/mg DNA in CD34+ SVF-cells) could be detected in both cell populations, and thus indicate the capacity for glycolysis (Scrutton and Utter, 1968; Schwandt et al., 1970) (Fig 6A, B & C). Herein the glycolytic enzymes GAPDH and LDH displayed the highest activities in both cell populations and were significantly higher than the measured PFK activities. Shonk et al. detected PFK, GAPDH and LDH activities in human whole adipose tissue homogenates in similar proportions (Shonk et al., 1964). As the PFK catalysis the flux-determining, non-equilibrium reaction of glycolysis making it the rate limiting step, it can be concluded, that there is higher capacity for glycolysis in CD34+ SVF-cells than in adipocytes. Kheterpal et al. found conflicting results regarding the capacity of glycolysis when they detected a higher GAPDH protein amount in adipocytes compared with the whole SVF and lower protein amounts of triosephosphate isomerase at the same time (Kheterpal et al., 2011). Anaplerosis of the glycolytic pathway from glycerol could be an explanation for this inverse behavior. The substrate of GAPDH, i.e. 3-phosphoglyceraldehyde, would then originate from glycerol, synthesized by the activities of the enzymes glycerol kinase, glycerol-3-phosphate dehydrogenase and triose phosphate isomerase (Nelson and Cox, 2011) instead of fructose-1,6-bisphosphate. All three enzymes have been identified in white adipose tissue or adipocytes respectively (Chakrabarty, Chaudhuri and Jeffay, 1983; Swierczynski et al., 2003; Kheterpal et al., 2011; Sledzinski et al., 2013). Glycolysis is increased in cells that proliferate actively (Vander Heiden, Cantley and Thompson, 2009). In contrast to adipocytes CD34+ SVF-cells possess proliferative potential (Strawford et al., 2004). Contrary to cultured adMSC that proliferate actively, cultured adMSC that do not proliferate have been shown to decrease their glycolytic capacity. Under the same in 
vitro conditions the activity of the marker enzyme of gluconeogenesis, FBPase, was below the detection limit (Meyer et al., 2018). In this study the activity of the FBPase was low but detectable (0.04 U/mg DNA in adipocytes; 0.01 U/mg DNA in CD34+ SVF-cells) (Fig. 6E). This deviation could demonstrate an adaptation to the in vitro conditions with a surplus of glucose available, compared to the in vivo situation (Cunha et al., 2016). 
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Thus, it may be concluded that in vivo adipocytes and CD34+ SVF-cells from adipose tissue keep up a metabolic flexibility to be able to facilitate gluconeogenesis if necessary. 
 
Fig. 6: Marker enzyme activities in adipocytes and the CD34+ SVF-cells. (A) PFK; (B) GAPDH; (C) LDH; (D) G6PDH; (E) FBPase; (F) GSR; (G) NAD-IDH; (H) NADP-IDH; (I) HOADH and (J) CK; activities were normalized to the overall DNA content of the cells (data displayed as medians of 4 donors; measurements as technical duplicates; *=significantly different; Mann-Whitney U Test, p < 0.05). Adapted from (Meyer et al., 2019)  
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Intermediates of glycolysis can be branched off to the PPP (Chandel, 2015). Rate-limiting enzyme of the PPP is the G6PDH. Similar activities were determined for the G6PDH (0.19 U/mg DNA in adipocytes; 0.98 U/mg DNA in CD34+ SVF-cells) as for PFK, suggesting a similar capacity for the PPP and glycolysis (Fig. 6D). Highly active proliferation in vitro has been associated with high G6PDH activity (Tian et al., 1998). These in vitro observations are confirmed by the data of this study where both cell types have been examined without prior subjection to in vitro conditions. Adipocytes that do not proliferate (Si, Yoon and Lee, 2007) display lower G6PDH activity. CD34+ SVF-cells that possess the potential to proliferate (Zuk et al., 2001) displayed higher G6PDH activity. All measured enzymes, that are involved in mitochondrial metabolism, showed significantly higher activities in adipocytes than in CD34+ SVF-cells. The activities of NAD-IDH (0.44 U/mg DNA in adipocytes; 0.14 U/mg DNA in CD34+ SVF-cells), NADP-IDH (1.63 U/mg DNA in adipocytes; 0.63 U/mg DNA in CD34+ SVF-cells) and HOADH (4.93 U/mg DNA in adipocytes; 0.92 U/mg DNA in CD34+ SVF-cells) indicate a distinguished role of mitochondrial and lipid metabolism in differentiated human adipocytes (Fig. 6G, H & I). This is substantiated by findings, that while mitochondrial proteins represent only 4.8 % of the total human proteome in adipocytes (Guda, Fahy and Subramaniam, 2004), 22 % of the overall protein amount were identified as of mito-chondrial origin (Xie et al., 2010). The difference in activity between adipocytes and CD34+ SVF-cells for the HOADH, have been documented in other studies in a similar fashion. Fain et al. documented enriched mRNAs encoding enzymes involved in lipid turnover in adipocytes compared to SVF-cells of human omental adipose tissue (Fain et 
al., 2008). When comparing in vitro adMSC with and without adipogenic stimulation, the capacities of HOADH displayed the same difference (Meyer et al., 2018). The NADP-IDH supplies NADPH for the antioxidative defense catalyzed by the GSR in mitochondria (Koh et al., 2004). No difference between the two examined cell populations was measured in GSR activity (0.65 U/mg DNA in adipocytes; 0.58 U/mg DNA in CD34+ SVF-cells) (Fig. 6F). Thus, the higher NADP-IDH activity measured in adipocytes compared to CD34+ SVF-cells may be derived from the cytosolic isoform that delivers reduction equivalents for lipid synthesis (Koh et al., 2004). Nevertheless, this issue needs further investigation, as the antioxidative defense system is complex. 
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Adipocytes displayed a CK activity that was almost three times higher compared to CD34+ SVF-cells (5.11 U/mg DNA in adipocytes; 1.82 U/mg DNA in CD34+ SVF-cells) (Fig. 6J). In white adipocytes CK activity might be facilitated as a phosphocreatine shuttle in order to overcome spatial restrictions of energy transport (Dzeja and Terzic, 2003). As the main volume of adipocytes is occupied by a monolocular lipid vacuole surrounded by only a thin layer of cytoplasm, a strictly diffusional transport from ATP-producing to ATP-consuming reactions might not suffice to supply all energy required (Wallimann et al., 1992). A similar pattern was documented when comparing CK activities in in vitro-cultured adMSC with and without adipogenic stimulation (Meyer et 
al., 2018). 
 Summary and discussion Study III - Energy metabolic capacities of 
human adipose-derived mesenchymal stromal cells in vitro and 
their adaptations in osteogenic and adipogenic differentiation 
For some clinical applications of adMSC an expansion and/or differentiation of the cells might be necessary. We have observed the substantial differences in the energy metabolic configuration of native adipocytes and CD34+ SVF-cells in connection with their diverging differentiation and proliferation potential. We thus hypothesized that the transition of adipose-derived progenitors from their in vivo to an in vitro environment would cause adaptations in the cell’s energy metabolism. To assess this hypothesis, we analyzed activities of major metabolic pathways in non-differentiating and differentiating adMSC. This work was published in Experimental Cell Research under the title “Energy metabolic capacities of human adipose-derived mesenchymal stromal cells 
in vitro and their adaptations in osteogenic and adipogenic differentiation”. After isolation and expansion adMSC were subjected to culturing conditions without differentiation stimuli as well as culturing conditions with osteogenic and adipogenic differentiation stimuli. After 7 and 21 d in non-stimulated adMSC cultures a 1.3-fold increase in cell number had occurred from day 7 to day 21. After 7 d of osteogenic stimulation the amount of cells was 1.4-fold higher than in non-stimulated adMSC. After 21 d in osteogenic culture the amount of cells had increased 3.7-fold compared to non-stimulated adMSC. In contrast, the cell numbers of adipogenically stimulated adMSC did not change significantly over the cultivation period of 21 d. At this 
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point of time the amount of cells in adipogenic cultures was 2.0-fold lower than in the non-stimulated ones. The viability of the cells was monitored via fluorescence microscopy and a mitochondrial metabolic activity assay. So, while the non-stimulated cultures displayed moderate proliferative activity, high proliferative activity was induced with osteogenic differentiation. This and the constant cell amount in the adipogenically differentiating adMSC, that indicates a lack of proliferative activity, have previously been shown for the used stimuli (Salamon et al., 2013). The measurement of the ALP activity was used to characterize the osteogenic differentiation. Osteogenic stimulation over 21 days led to a distinct positivity for ALP activity with a 5-fold increase compared to non-stimulated cultures. The ALP activity of adipogenically stimulated adMSC was 6-fold lower than the ALP activity in osteogenically stimulated adMSC. Adipogenic differentiation was examined by the quantification of the formation of lipid-filled vacuoles. In non-stimulated adMSC no lipid accumulation was detectable, whereas adipogenically stimulated adMSC showed numerous lipid-filled vacuoles yielding 5-6-fold higher values compared to those in non-stimulated and osteogenic cultures. The detected levels of ALP activity clearly show that the osteogenic stimulation of adMSC led to osteogenic differentiation. The osteogenic differentiation initialized by the stimulants used in this study, has previously been shown to be accompanied by increased expression of the osteoblastogenic marker ZBTB16 (zinc finger and BTB domain containing 16) (Salamon et al., 2014) and increased expression of osteocalcin and osteopontin (Lee et al., 2003; Astori et al., 2007). The detected lipid vacuole formation in the adipogenic cultures verified the adipogenic differentiation of the stimulated adMSC. The differentiation protocol applied in this study has previously been shown to also induce expression of leptin, glucose 
transporter GLUT4, PPARγ2 (peroxisome-proliferating activated receptor γ), LPL (lipoprotein lipase), and aP2 (adipocyte protein 2) (Zuk et al., 2001, 2002; Astori et al., 2007; Liu et al., 2007), that are established markers of adipogenic differentiation. After 7 and 21 d in culture with and without differentiation stimuli, important energy metabolic pathways were examined by measuring the maximum activities of marker enzymes. The PFK is the regulatory enzyme of glycolysis. In non-differentiating cultures, PFK activity increased during cultivation (0.25 U/mg DNA and 0.5 U/mg DNA after 7 and 21 d) (Fig. 7A). The GAPDH, also an enzyme of glycolysis, showed the highest 
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activities of all enzymes tested (e.g. 48 U/mg DNA after 7 d) (Fig. 7B). The GAPDH activity was increased 1.6-fold after 21 d (75 U/mg DNA). The LDH, that facilitates the reversible conversion of pyruvate to lactate, was 2.3-fold higher in activity after 21 d in culture compared to its activity after 7 d (16 U/mg DNA and 7 U/mg DNA respectively) (Fig 7C). The G6PDH, marker enzyme of the PPP, showed constant capacities in non-differentiating cells (3.1 U/mg DNA after 7 d and 3.5 U/mg DNA after 21 d) (Fig. 7D). The maximum activities of the marker enzymes NAD-IDH and NADP-IDH were measured in order to evaluate the relevance of the TCC. At all points of time under all cultivation conditions the NAD-IDH activity was below the detectable level. In non-differentiating cultures the NADH-IDH showed a capacity of 1.2 U/mg DNA after 7 d, which did not change significantly during cultivation (1.0 U/mg DNA after 21 d) (Fig. 7E). The HOADH, mitochondrial marker enzyme of fatty acid oxidation, showed low maximum activities (0.5 U/mg DNA and 0.6 U/mg DNA after 7 and 21 d) (Fig 7F). The GSR has a function in the antioxidative defense system where it facilitates the reduction of glutathione disulfide to glutathione. Maximum activities in the non-differentiating cultures were 0.9 U/mg DNA after 7 d and 1.7 U/mg DNA after 21 d (Fig. 7G). CK, that is involved in buffering and recovery of ATP displayed capacities of 2.1 U/mg DNA after 7 d and 2.2 U/mg DNA after 21 d in non-differentiating adMSC cultures (Fig 7H). 
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Fig. 7: Marker enzyme activities in adMSC in vitro. non-differentiating (US), osteogenically (OS) or adipogenically (AS) differentiating after 7 and 21 d, (A) PFK, (B) GAPDH, (C) LDH, (D) G6PDH, (E) NADP-IDH, (F) HOADH, (G) GSR, (H) CK; Activities normalized to the overall DNA content of the cells (data displayed as medians of 8 donors; measurements as technical duplicates; *significantly different from US cultures at the respective time point; *=significantly different; Mann-Whitney U Test, p < 0.05). Adapted from (Meyer et al., 2018)  The total increase of maximum PFK activity in osteogenically differentiating adMSC was 13-fold from 0.5 U/mg DNA after 7 d to 6.5 U/mg DNA after 21 d. The increases in maximum GAPDH and LDH activities were much lower. The increase of GAPDH was 1.8-fold (55 U/mg DNA and 101 U/mg DNA after 7 and 21 d) the increase LDH activity was 4-fold (8 U/mg DNA and 35 U/mg DNA after 7 and 21 d). In 
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osteogenically differentiating cultures the ratio GAPDH/PFK was 15 after 21 d. This is 15-fold lower than in the non-differentiating cultures. G6PDH activity increased 2.6-fold during osteogenic differentiation (4.4 U/mg DNA after 7 d and 11.4 U/mg DNA after 21 d). NADH-IDH activity also increased over the period of osteogenic culture (2.4 U/mg DNA after 7 d and 3.9 U/mg DNA after 21 d). It was thus significantly higher after 21 d than in the non-differentiating cultures. The HOADH activity after 7 d was slightly higher than in non-differentiating cells (0.9 U/mg DNA). It increased 2.9-fold to 2.6 U/mg DNA after 21 d. The GSR capacity was more than twice as high after 7 d compared to the non-differentiating cultures (2.2 U/mg DNA) and increased over the osteogenic culturing period (6.3 U/mg DNA after 21 d). As in the non-differentiating cultures, the CK capacities did not show significant changes over the culturing period in the osteogenically differentiating cultures but were overall higher (4.1 U/mg DNA and 3.9 U/mg DNA after 7 and 21 d). The maximum activities of PFK, GAPDH and LDH measured in adipogenically differentiating cultures were overall lower than in the non-differentiating cultures. There was a 2-fold increase of the maximum PFK activity over the culturing period (0.2 U/mg DNA after 7 d and 0.4 U/mg DNA after 21 d). At the same time GAPDH activity remained the same (20 U/ mg DNA after 7 and 21 d). During adipogenic differentiation a 2.7-fold increase of the LDH activities (3.7 U/mg DNA after 7 d and 10 U/mg DNA after 21 d) was observed. The ratio GAPDH/PFK decreased from 135 after 7 d to 61 after 21 d. As for the GAPDH, the G6PDH activity was below the activities in non-differentiating cultures as well and did not vary significantly over the adipogenic cultivation period (2.8 U/mg DNA after 7 d and 2.2 U/mg DNA after 21 d). In contrast, the NADH-IDH activities were significantly higher after 7 and 21 d than those in the non-differentiation cultures (2.1 U/mg DNA and 2.5 U/mg DNA respectively). The HOADH activities detected in adipogenically differentiating adMSC were the highest overall (1.4 U HOADH/mg DNA after 7 d and 4 U/mg DNA after 21 d). The GSR showed a similar capacity compared to osteogenically differentiating cells after 7 d (2.3 U/mg DNA). The increase over the culturing period was less pronounced (3.5 U/mg DNA). Like the HOADH, the CK displayed higher capacities in the adipogenically differentiating cultures than in the non-differentiating and osteogenically differentiating cultures (5.3 U/mg DNA and 5.9 U/mg DNA after 7 and 21 d). 
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↑ Fig. 8: Relative mitochondrial mass of 
adMSC in vitro. mitochondrial protein norma-lized to cell number after 7 & 14 d in control (US) and in osteogenic (OS) or adipogenic diffe-rentiation (AS). (data displayed as medians of 5 donors; measurements as technical duplicates; *=significantly different; Mann-Whitney U Test, p < 0.05). Adapted from (Meyer et al., 2018) 
← Fig. 9. Isoenzyme gene expression levels of 
adMSC in vitro in control (US) and osteogenic (OS) or adipogenic (AS) culture after 7 and 14 d. (A) LDH isoforms LDHA and LDHB, (B) IDH isoforms IDH1, IDH2 and IDH3A, (C) CK iso-forms CKB, CKMT1B and CKMT2, normalized to 18s RNA-expression (data displayed as medians of 3 donors; measurements as techni-cal duplicates; all culture conditions were compared within one time point; *=significantly different; Mann-Whitney U Test, p < 0.05). Adapted from (Meyer et al., 2018)  The capacities measured for PFK, GAPDH and LDH suggest a high capacity of carbohydrate catabolism, i.e. glycolysis, in non-differentiating and osteogenically differentiating adMSC. This is accompanied by the high proliferative activity that was found in those cell cultures. Cell division as well as differentiation require the de novo synthesis of macromolecules like proteins and DNA (Ralph J DeBerardinis et al., 2008; Musumeci et al., 2014). A preference for carbohydrate metabolism yielding lactate under aerobic conditions has been observed in various proliferating cell cultures (Peters et al., 2009; Vander Heiden, Cantley and Thompson, 2009). This phenomenon has been defined as the Warburg effect (Warburg, 1956). The carbon flux through biosynthetic pathways might be increased by facilitation of this less efficient pathway (Vander Heiden, Cantley and Thompson, 2009). Despite the indications of some of the present data, an explicit deduction on the manifestation of the Warburg effect in in vitro proliferating adMSC cannot be made solely based on our present data. The presence of LDH activity and its increase within the cultivation period might also imply the ability of adMSC to utilize lactate as an aerobic substrate. This is supported by the striking dominance of the RNA expression of the B subunit of LDH (heart type) (Fig. 9A) which 
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shows a preference for the conversion of lactate to the 3-carbon compound pyruvate (Dawson, Goodfriend and Kaplan, 1964). A capacity for carbohydrate anabolism cannot be anticipated from the results attained in this study, as no activities of the marker enzyme of gluconeogenesis, FBPase, were at a detectable level at any time point under any of the culturing conditions. The use of lactate for gluconeogenesis is thus unlikely. Previous studies have yielded controversial results regarding the metabolism of MSC during osteogenic differentiation. Pattappa et al. and Chen et al. demonstrated a suppression of glycolysis in osteogenically differentiating bmMSC, suggesting a proportionate increase in oxidative phosphorylation (Chen et al., 2008; Pattappa et al., 2011). Shum et al. reported steady levels glycolysis upon osteogenic differentiation of bmMSC. At the same time oxidative phosphorylation increased (Shum et al., 2016). Our results show a simultaneous increase of carbohydrate metabolism, oxidative phosphorylation and β-oxidation upon osteogenic differentiation accompanied by osteogenic differentiation. These divergent findings may result from different analytical methods as well as the fact that, in the other studies, mostly bmMSC were examined (Quarto et al., 2010). Also cell metabolism is likely influenced by variations in cell culturing, e.g. as displayed in the differences of medium composition with partially supraphysiological levels of glucose, glutamine and pyruvate (Brand and Nicholls, 2011). No proliferative activity was detected in adipogenically differentiated adMSC. Thus, the steady GAPDH activities and the slight increase of PFK activity over the culturing period may be caused by the initiation of lipid synthesis. During anabolic lipid synthesis, dihydroxyacetone phosphate is diverted from glycolysis prior to the action of GAPDH (Lunt and Vander Heiden, 2011). As deducible from studies with rat white adipose tissue and the 2.7-fold increase of LDH within 2 weeks recorded in the present study, the main role of LDH may be the conversion of excess available lactose into pyruvate in order to limit tissue self-utilization as a substrate (Arriarán et al., 2015). This is again supported by the dominance of the expression of the LDH B subunit (Fig. 9A). The G6PDH and thus the PPP competes with glycolysis for glucose metabolism. The relatively high G6PDH activities in non-differentiating and differentiating adMSC indicate the importance of the PPP for anabolism (Tian et al., 1998; Peters et al., 2009). When compared, the measured G6PDH activities were higher than the control enzyme of glycolysis PFK, under each culturing condition. A high ratio of G6PDH/PFK might be typical for proliferating and/or differentiating cells, as these are characterized by 
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relatively high anabolic activity (Peters et al., 2009). Besides the provision of pentoses for the biosynthesis of macromolecules like nucleic acids (Chandel, 2015), the G6PDH also delivers the reduction equivalent NAPDH+H+ which is essential for biosynthesis (particularly lipogenesis) and antioxidative defense (Horecker, 1976).  Lipid synthesis entails a high consumption of NAPDH+H+ in the cytoplasm by the NADP-IDH encoded by IDH1. Correspondingly, the expression level of IDH1 prevails in adipogenically induced adMSC (Fig. 9C) where lipids are evidently accumulated in vacuoles. This is substantiated by the fact, that the regulation of the PPP capacity is strongly dependent on the regulation of lipid synthesis (Kather, Rivera and Brand, 1972). A part of the measured NADP-IDH might also be located in the mitochondria because IDH is required for the TCC and an activity of mitochondrial NAD-dependent IDH activity could not be detected (Nelson and Cox, 2011). The expression of IDH2 RNA in adMSC, that increases during osteogenesis and adipogenesis substantiates the presence of mitochondrial NADP-IDH. Also, IDH3A RNA, the mitochondrial catalytic NAD-IDH subunit, is expressed in adMSC under all culturing conditions. The NAD-IDH contains two different regulatory subunits which allow allosteric regulation of the activity, particularly by cell energy charge (e.g. ADP/ATP) (Hartong et al., 2008). Translation to an active NAD-IDH can still be suppressed through alternatively spliced gene products of the regulatory subunits. Thus, the expression of the catalytic α-subunit of IDH3A does not represent the total expression of NAD-IDH. This might be the reason for the apparent discrepancy between the measured NAD-IDH activity and the IDH3A expression level (Fig. 9B). While in proliferating cells the NADP-IDH is the prevailing IDH isoform (Peters et al., 2009) NAD-IDH is particularly present in tissues with a high respiratory ATP turnover, like aerobic muscles. In proliferating cells most of the carbon that enters the TCC will be directed towards biosynthetic pathways rather than ATP production (Ralph J. DeBerardinis et al., 2008). Thus, citrate could be diverted away from the TCC before it is converted to α-ketoglutarate by the NAD-IDH, e.g. for fatty acid synthesis. In contrast to the irreversible reaction of NAD+-dependent conversion of isocitrate to oxoglutarate, the NADP+-dependent reaction is reversible. Therefore, the NADP-IDH might be favored in biosynthetically active cells. Using the anaplerotic pathway of glutaminolysis, glutamine can compensate for a lack of glucose not only for ATP-production but also for the supply of anabolic precursors (Board, Humm and Newsholme, 1990; Smolková and Jezek, 2012).  
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As our in vitro measurements of HOADH activity and quantification of mitochondria show (Fig. 7F and Fig. 8), the capacity for ß-oxidation increases distinctly under adipogenic as well as osteogenic differentiation. Our results, are substantiated by different studies that reported a constant mitochondrial mass during osteogenic differentiation (Chen et al., 2008; Shum et al., 2016) and a distinct increase in mitochondrial mass during adipogenic differentiation (Wilson-Fritch et al., 2003; Zhang 
et al., 2013). It is still a matter of controversy if the fatty acid synthesis and ß-oxidation do occur simultaneously within one cell. While studies with white adipose tissue have shown that lipolysis is inhibited during anabolic phases (Chandel, 2015; Rutkowski, Stern and Scherer, 2015), the conversion of white to brown adipocytes entails an upregulation of both fatty acid anabolic and catabolic pathways (Barquissau et al., 2016). It remains to be elucidated if in vitro adipogenic stimulation leads to a homogenous cell population where fatty acid synthesis and ß-oxidation actually do occur simultaneously within one cell, or if it leads to a heterogenous cell population where some cells facilitate fatty acid synthesis while others facilitate ß-oxidation. A low production of ROS and thus low activity of oxidative phosphorylation is indicated by low GSR activities in non-differentiating, proliferating cells. In proliferating thymocytes a low oxidative phosphorylation activity has also been shown (Brand and Hermfisse, 1997). The enhanced anabolic activities during in vitro osteogenic and adipogenic differentiation might increase the demand for a regeneration of the detoxification system of reactive oxygen species (Chakravarthi, Jessop and Bulleid, 2006). This could be reflected by the significant increase of GSR activity in osteogenically and the slight increase in adipogenically differentiating adMSC. Furthermore, an increased oxygen consumption has been correlated with the adipogenic differentiation of bmMSC and adipose progenitors, while antioxidative defense enzymes were upregulated at the same time (Heimburg et al., 2005; Zhang et al., 2013). These together with our data suggest an association of the mitochondrial oxidative activity, enhanced anabolism and regulation of antioxidative defense. This will need further validation in order to find conclusions on actual correlative and causal connections. CK regenerates ATP for seconds in cells with temporarily high or fluctuating energy demands (Wallimann and Hemmer, 1994b). Under all culturing conditions adMSC displayed CK activities. The gene expression data imply that mitochondrial CKs 
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were expressed particularly in adipogenically stimulated cells, suggesting that adipogenic stimulation shifted the energy metabolism towards a more oxidative metabolism than osteogenic stimulation did. Also, a functional phosphocreatine-CK shuttle has been found in human skin, that was characterized as having high metabolic rates and energy turnover. In these cells the shuttle was mainly made up of the brain type CK and the ubiquitous mitochondrial CK (Wallimann and Hemmer, 1994b; Schlattner et al., 2002). With progressing adipogenic differentiation the expression levels of CKB, CKMT1B and CKMT2 increase (Fig. 9C). Thus, adipogenically differentiating adMSC show a metabolic phenotype that is characteristic for rapid ATP turnover even though they are not actively proliferating. 
  
Fig. 10: Schematic depiction of the metabolic changes in adMSC in vitro during (A) osteogenic and (B) adipogenic differentiation in relation to non-differentiating adMSC (increased↑, decreased↓; Ox Phos: oxidative phosphorylation, PCreatine: phosphocreatine). Adapted from (Meyer et al., 2018)  According to the present data osteogenically differentiating adMSC attained a strongly proliferative phenotype that entailed an increase in the capacity of all examined energy metabolic pathways. Adipogenic differentiation of adMSC, characterized by a lack of proliferation, shift their energy metabolic capacity towards lipid metabolism (Fig. 10).   
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5 Conclusion & future prospects Adipose tissue is a simply available source of adult stem cells with regenerative therapeutic potential. It was demonstrated that adipose tissue harvested with water jet-assistance yields cells in numbers and viability competitive with other aspiration methods. The adMSC isolated from WAL tissue display plastic adherence and mesenchymal differentiation potential, making it a valid source for adMSC isolation. Two distinct cell populations from adipose tissue, adipocytes and CD34+ SVF-cells were examined for their energy metabolic configuration. The enzymes related to mitochondrial and lipid metabolism showed a higher representation in adipocytes, whereas the activity of the rate-limiting enzyme of glycolysis was higher in the CD34+ SVF-cells. These distinctions exist in parallel with the potential of CD34+ SVF-cells to proliferate and differentiate, whereas adipocytes do not.  The transition of adMSC from their in vivo to an in vitro environment with osteogenic and adipogenic differentiation stimulation led to changes in the cell’s proliferative behavior together with adaptations of their respective energy metabolism. Osteogenically differentiating adMSC attained a strongly proliferative phenotype that entailed an increase in the capacity of all examined energy metabolic pathways. Adipogenic differentiation of adMSC, characterized by a lack of proliferation, is accompanied by decreasing capacities of PPP and carbohydrate metabolism. At the same time, growing capacities for oxidative phosphorylation and β-oxidation are indicated by the increasing mitochondrial enzyme activities. Thus, adipogenically differentiating adMSC display a shift of their energy metabolic capacity towards lipid metabolism. We thus observed a similar relationship between the energy metabolic configuration and the proliferation potential as we did before in the two native cell populations of the adipose tissue. Considering the limitations regarding the comparability and interpretation of results in comparison to available literature, due to differences in the applied methodologies, further examinations will be needed to decipher the metabolic configurations of the different cell types of adipose tissue. As a next step the analysis of the uptake and release of radio-labeled metabolites could elucidate the metabolic structure of the cells on an additional level. Furthermore, it is essential to determine if the observed relationships between cell behavior and energy-metabolic phenotype are 
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actual correlations and causal relations. In order to achieve this, knock down experiments of the expression of single enzymes or groups of enzymes could be considered in order to observe changes in the differentiation and proliferation potential of the cells. Knock out experiments should be refrained from as a complete depletion of the examined enzymes might likely render the cells nonviable. Moving forward to achieve insights on the more clinical aspects of the cells it will be of interest to relate specific donor patient parameters like body mass index, age and/or tissue depot localization to the amount and viability of the contained adipocytes and CD34+ SVF-cells. Also, the differentiation potential and metabolic phenotype of adMSC in relation to the mentioned donor patient parameters can be of clinical interest.  With the present work we were able to contribute to the characterization of the energy metabolism of distinct cell types of the human adipose tissue in the native state and after in vitro culturing. We were thus able to add to the groundwork needed for further examinations of the cellular metabolism of human adipose tissue in the clinical as well as the laboratory setting as can be seen in ongoing investigations the emission of volatile organic compounds between non-differentiating and adipogenically differentiating adMSC (Klemenz et al., 2019).   
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Abstract 
Background: In recent years the therapeutic application of extracted adipose tissue for autologous fat grafting and the application of adipose tissue-derived 
mesenchymal stem cells (adMSC) isolated thereof has progressed. Water-jet assisted liposuction (WAL) is 1 procedure for harvesting adipose tissue and pro- 
vides a favorable aesthetic outcome combined with high tissue protection. Tissue aspirated by WAL has been successfully applied in grafting procedures. 
Objectives: The aims of this study were to conﬁrm the tissue viability and to understand the abundance and mesenchymal differentiation capacity of stem 
cells within the tissue. 
Methods: We analyzed tissue integrity of WAL tissue particles via ﬂuorescence microscopy. The adMSC content was determined by isolating the cells from 
the tissue. The mesenchymal differentiation capacity was conﬁrmed with cytochemical staining methods. 
Results: The stromal vascular fraction of WAL tissue showed high viability and contained an average of 2.6 × 105 CD34-positive cells per milliliter of tissue. 
Thus WAL tissue contains a high number of stem cells. Furthermore adMSC isolated from WAL tissue showed typical mesenchymal differentiation potential. 
Conclusions: WAL of adipose tissue is well suited for autologous fat grafting because it retains tissue viability. Furthermore it is a valid source for the subse- 
quent isolation of adMSC with multipotent differentiation potential. 
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Therapeutic 
 
 
 
Through the therapeutic application of extracted  adipose    
tissue for autologous fat grafting, liposuction has become 
an important issue.1,2 In this context the properties of the 
aspirated tissue, like tissue particle size, viability, adipo- 
cytes number, and other adipose-resident cell types or 
functional structures (eg, blood vessels) need to be investi- 
gated in closer detail. 
Adipose tissue is composed of various cell types (adipo- 
cytes, endothelial cells, ﬁbroblasts, blood and blood-derived 
cells, and adipose tissue-derived mesenchymal stem cells 
[adMSC]).3-6 Enzymatic digestion of the adipose tissue and 
depletion of adipocytes yields the so-called stromal vascular 
fraction (SVF), which already has successfully been used in 
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different clinical approaches such as supplementation of fat 
grafts and treatment of urinary incontinence and chronic 
wounds.7-10 
Zuk et al were the ﬁrst to describe adMSC.6 By their 
intrinsic capacity for self-renewal and multipotent mesen- 
chymal differentiation, adMSC are important in tissue 
homeostasis and regeneration.11 Human adMSC were 
shown to directly differentiate into osteoblasts and endo- 
thelial cells in a nonunion fracture model.12 In case studies, 
human adMSC were already successfully used to treat 
critical-size calvaria13 and maxilla defects.14 Furthermore, 
adMSC were demonstrated to engraft at long-term at the 
transplantation site.15,16 
Compared with bone marrow, adipose tissue can be har- 
vested in higher amounts, with a higher abundance of stem 
cells and less donor-site morbidity.17 adMSC are present at 
a concentration of roughly 50,000 cells per mL adipose 
tissue (approximately 7% of the cells found in enzyme- 
dissolved adipose tissue),18,19 which is 100-fold higher than 
found for mesenchymal stem cells (MSC) isolated from 
bone marrow.17 Also, the use of adult stem cells does not 
entail the ethical concerns that the use of embryonic stem 
cells does. Finally adMSC fulﬁll all MSC characteristics 
deﬁned by the International Society for Cellular Therapy, 
the International Federation of Adipose Therapeutics and 
Sciences, and others.20,21 
Adipose tissue can be harvested by various methods, such 
as resection, conventional liposuction, syringe-aspiration, 
and others.2 The speciﬁc liposuction methodology applied 
may impact the viability of cells present in the harvested 
tissue.22,23 Water jet-assisted liposuction (WAL) is a liposuc- 
tion procedure that applies the tumescent solution as a thin, 
fan-shaped, targeted, pulsating jet.24,25 The cannula used 
during the operation comprises 2 channels that make it possi- 
ble to inﬁltrate the tumescent solution and aspirate the 
emerging water and fat suspension at the same time. Thus, 
the amount of ﬂuid inﬁltrated into the patient is much lower 
than during conventional liposuction procedures, which 
lowers the risk of cardiovascular side effects. This aims at en- 
suring the desired aesthetic outcome and safety of the patient 
as well as protecting the harvested adipose tissue. Our exami- 
nations assure quality of autologous fat grafts obtained by 
WAL and show differentiation reliability of mesenchymal 
stem cells isolated from WAL tissue. To this end, we exam- 
ined the viability, number and adipogenic or osteogenic dif- 
ferentiation potential of adMSC isolated from WAL-harvested 
adipose tissue. 
 
 
METHODS 
If not stated otherwise, all plastic-ware was from Greiner 
Bio-One (Frickenhausen, Germany) and all reagents were 
from Sigma-Aldrich (Steinheim, Germany). 
Donors 
This study examined 13 consecutive patients (1 man and 
12 women) over a 27-month period from August 2012 to 
October 2014. The patients gave written informed consent 
that they were willing to take part in this study. The study 
was approved by the ethics committee of Rostock University 
Medical Center under the registration number A2013-0112, 
and it complies with the ethical standards deﬁned by the 
World Medical Association Declaration of Helsinki. 
 
Aspiration of Human Adipose Tissue 
The liposuction procedure was carried out according to the 
BEAULI protocol described by Ueberreiter et al.26 Brieﬂy, a 
pulsating water jet was applied for inﬁltration with simulta- 
neous suction. For inﬁltration the ranges 1 to 3 are avail- 
able, ranging from 90 mL/minutes ± 15% to 130 mL/ 
minutes ± 15%. The inﬁltration solution used was classical 
Klein’s tumescence solution that was prewarmed to 37 to 
38°C. The cannulas for harvesting have an outer diameter 
of 38 mm and bear sharp tips. After the ﬁrst inﬁltration, 
there was no required waiting period before the suction 
could be commenced. The negative pressure for the suction 
was adjusted to 500 mbar. 
 
Viability Assessment of the WAL-Isolated 
Tissue 
In order to evaluate the viability of the aspirated tissue, a 
live/dead staining was performed as described previously.27 
Therefore, the aspirated tissue was incubated for 10 minutes 
with cell culture medium (Dulbecco’s Modiﬁed Eagle 
Medium (DMEM), Life Technologies, Darmstadt, Germany) 
supplemented with 3 µM Hoechst 33342 (Bis-benzimide 
H33342 trihydrochloride), 500 nM propidium iodide, and 
1 µM calcein acetoxymethyl ester (both Life Technologies). 
The tissue was then analyzed by ﬂuorescence microscopy 
(Carl Zeiss Microscopy GmbH, Göttingen, Germany) using 
the blue, green, and red emission ﬁlters. Emission maxima 
of the dyes are 460 nm (Hoechst 33342), 516 nm (calcein), 
and 617 nm (propidium iodide). Excitation maxima are 
360 nm (Hoechst 33342), 496 nm (calcein), and 535 nm 
(propidium iodide). 
 
Isolation and Culture of adMSC 
As described previously,28 adipose tissue was digested 
using 1.6 mg/mL Collagenase NB4 (SERVA, Heidelberg, 
Germany), a mixture of a neutral protease and the collage- 
nases I and II in phosphate-buffered saline (PBS) with 
calcium and magnesium (PAA Laboratories, Coelbe, 
Germany). Through a series of steps of washing in PBS 
with 10% fetal calf serum (FCS; PAN Biotech, Aidenbach, 
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Germany) and centrifugation, the SVF was separated from 
the adipose tissue remains. At this point the SVF cell 
number and content of CD34-positive cells were determined 
with ﬂow cytometry (see Flow Cytometric Analysis section). 
The cells liberated from the digested tissue were incubated 
for 24 hours under standard cell culture conditions (5% CO2 
and 37°C in a humidiﬁed atmosphere). CD34-positive cells 
were isolated from total plastic-adherent cells using a mag- 
netic bead depletion system (Life Technologies). During 
this selection procedure, the number of cells that were 
plastic adherent after 24 hours and the number of cells that 
were plastic adherent and CD34 positive were determined 
using the Scepter cell counter (Merck KGaA, Darmstadt, 
Germany). Since the bead depletion is a standard procedure 
to attain the cells used for the experiments, we desisted from 
the reapplication of ﬂow cytometry. After 3 passages, 
adMSC were seeded into experimentation at 20,000 cells 
per cm2. Absence of Mycoplasma species was conﬁrmed 
microscopically after DNA staining. 
AdMSC were cultured in standard culture medium, adipo- 
genic differentiation stimulating medium, and osteogenic 
differentiation-stimulating medium. Standard culture medium 
was DMEM, high glucose, GlutaMAX-I, supplemented with 
1% penicillin/streptomycin (100 U/mL and 100 µg/mL; both 
Life Technologies), and 10% FCS. For adipogenic stimulation, 
500 μM 3-isobutyl-1-methylxanthin (SERVA), 10 μM insulin, 
1 μM dexamethasone, and 200 μM indomethacin (Fluka, 
Seelze & Buchs, Germany) were added to standard culture 
medium. For osteogenic stimulation, standard culture medium 
was supplemented with 0.25 g/L ascorbic acid, 1 μM dexame- 
thasone, and 10 µM β-glycerophosphate (Fluka). At conﬂu- 
ence, cultivation in standard and differentiation-inducing 
media began, termed day 0, and took up to 35 days. Change of 
medium was done every 2 to 3 days. 
 
Flow Cytometric Analysis 
In order to quantify the CD34 positive cell population of the 
SVF, isolated cell-suspension specimens from 7 patients were 
stained using a CD34 single platform staining kit (Stem-Kit, 
Beckman-Coulter, Krefeld, Germany). The Stem-Kit Reagents 
consist ofa 2-color ﬂuorescent (CD45-FITC/CD34-PE) murine 
monoclonal antibody reagent, a 2-color murine ﬂuorescent 
(CD45-FITC/isoclonic control-PE) reagent to check the non- 
speciﬁc binding of the CD34-PE monoclonal antibody, a 
nucleic acid viability dye (7-amino-actinomycin-D/7-AAD), a 
reagent (ammonium chloride) to lyse erythrocytes, and 
Stem-Count ﬂuorospheres for absolute count determination 
of CD34-positive cells. Therefore, tubes were preﬁlled with 
20 µL of a mixture of CD45-FITC (clone J33) and CD34-PE 
(clone 581) and 20 µL of 7-AAD-solution. 100 µL of cell sus- 
pension was added and incubated for 15 minutes at room 
temperature (20°C) in the dark. A second incubation for 10 
minutes was done after addition of 2 mL lysis reagent. 100 µL 
Stem-Count ﬂuorospheres were added to the cell suspension 
directly before measurement. The ﬂow cytometer FC500 
Flow Cytometer (Beckman-Coulter) was equipped with a 
20 mW argon-ion-laser providing excitation at a wavelength 
of 488 nm. 
Analysis was done following a modiﬁed ISHAGE protocol29 
for single platform analysis.30 Cells were gated for CD45 and 
7-AAD-negative cells to exclude leucocytes and dead cells. 
Viable CD34-positive cells and ﬂuorospheres were counted 
using the CXP analysis software (Beckman-Coulter). The stem 
cell concentration was then calculated on the basis of the ﬂuo- 
rosphere concentration provided by the test kit. 
 
Quantiﬁcation of Cell Number 
The cell number in tissue from 8 individuals was deter- 
mined by crystal violet staining as described previously.28 
Crystal violet stains the negatively charged cellular DNA via 
ionic attraction31 in a linear fashion.32 
 
Analysis of Mesenchymal Differentiation 
Analysis of Adipogenic Differentiation 
Intracellular accumulation of lipids in the isolated adMSC of 
5 individuals was detected by ﬂuorescence staining of lipid 
vacuoles after 14 days of culture as described previously.33 To 
this end the cells were washed with PBS and ﬁxed in 4% 
paraformaldehyde (PFA). After washing with PBS, the cells 
were incubated in the Bodipy staining solution (1 µg/mL 
150 mM NaCl, Life Technologies) in the dark. The cells were 
then washed with PBS and H2O. The ﬂuorescence intensity 
was measured in a ﬂuorescence microplate reader (TECAN, 
Crailsheim, Germany) using an excitation wavelength of 
480 nm and an emission wavelength of 515 nm. Fluorescence 
microscopy was done to document the formation of lipid vac- 
uoles within the cells using an Axiocam MRc ﬁtted to an Axio 
Scope.A1 (Carl Zeiss Microscopy GmbH). 
 
Analysis of Osteogenic Differentiation 
Quantiﬁcation of alkaline phosphatase (ALP) activity in the 
isolated adMSC of 6 patients and the extracellular matrix 
(ECM) calcium content in the isolated adMSC of 4 patients 
were used to detect osteogenic differentiation of the cells as 
previously described.28 For photo documentation of ALP 
(liver/bone/kidney isoenzyme) activity, cells were stained 
with a solution of 67 mM 2-Amino-2-methyl-1.3-propanediol 
(AMPED), 2.7 mM Naphtol AS-MX phosphate, and 2.7 mM 
Fast Red Violet LB Salt in H2O. Quantiﬁcation of ALP activity 
was done after 21 days of culture by washing cells with 
Tris-buffered saline and permeabilizing lysis buffer (1% 
Tween 20 and 100 mM phenylmethanesulfonyl ﬂuoride in 
H2O) and incubating with ALP substrate solution (10 mM 
para-nitrophenylphosphate (pNPP), 100 mM AMPED, and 
5 mM MgCl2 in H2O for 1 hour under standard culture 
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conditions. To stop ALP activity, 2 M NaOH was added. The 
absorbance of the supernatant was quantiﬁed in a micro- 
plate reader (anthos Mikrosysteme) at 405 nm. 
For the visual documentation of the calcium deposition 
in the ECM, the cells were stained with 30 mM Alizarin Red S 
dissolved in H2O. Pictures were taken with the 
camera AxioCam ICc1 ﬁtted to an Axiovert 25 (Carl Zeiss 
Microscopy GmbH). Quantiﬁcation of ECM calcium content 
based on Ca2+ complexation by ortho-cresolphthalein was 
done after 35 days. Brieﬂy, after washing cells with PBS and 
ﬁxation with 4% PFA pre-warmed to 37°C, cells were 
washed with H2O, and cresolphthalein buffer (0.1 mg/mL 
ortho-cresolphthalein complexon, 1 mg/mL 8-hydroxy quin- 
oline, and 6% of 37% HCl in H2O) was added. After incuba- 
tion for 5 minutes at room temperature (19°C to 21°C), AMP 
buffer (15% 2-Amino-2-methyl-1-propanol [AMP] in H2O, 
pH 10.7) was added and incubated for 15 minutes at room 
temperature (20°C). The optical density of the supernatant 
was quantiﬁed in a microplate reader (anthos Mikrosysteme) 
at 580 nm. 
 
Data Illustration and Statistics 
All measurements were performed in triplicate. Data are 
illustrated as bar and line charts as well as box plots and 
were created using the R software environment for statisti- 
cal computing and graphics.34 The data displayed are the 
medians with positive and negative error bars representing 
the third and ﬁrst quartile, respectively. Since the data 
obtained were in most cases not normally distributed, 
testing for signiﬁcance in the difference between 2 datasets 
was done using the nonparametric Mann-Whitney U test. 
The level of signiﬁcance was set to a P-value of lower or 
equal to .05 (P ≤ .05) and calculated using R. 
 
RESULTS 
The average patient age was 42 years (range, 24-59 years). 
All patients were healthy adults seeking contouring of one 
or more of the following areas: arms, hips, buttocks, upper 
and lower abdomen, upper and lower back, ﬂanks, inner 
thighs, and outer thighs. The patients had an average body 
mass index of 25.8 (range, 21-35). The time from tissue 
harvest to cell isolation was less than 20 hours. 
 
Viability of the Aspirated Tissue 
The combined live/dead staining of WAL tissue resulted in 
a comprehensive green ﬂuorescence emission of the tissue 
and thus indicates its viability, while the nuclei of all cells 
are stained in blue (Figure 1A). A thin green circumferential 
ﬂuorescent line reﬂects the spherical shape of the mature 
adipocytes. The biggest part of the adipocytes is ﬁlled by 
 
 Figure 1. Live/dead-stained adipose tissue directly after the 
isolation by WAL (A; green: viable cells, red: dead cells, blue: 
nuclei); detail from isolated tissue showing vasculature-like 
structures (B); single cell suspension resulting from enzymatic 
digestion of the tissue (C). Most cells showed an intensive 
green staining and were thus identiﬁed as viable. A number of 
blood vessel-like structures were detectable (arrows). Only a 
few dead cells (red ﬂuorescence) were found. 
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  Figure 2. Quantiﬁcation of cell amounts after different steps of 
isolation (cell concentration in the SVF; concentration of 
CD34-positive cells within the SVF; concentration of 
plastic-adherent cells after 24 hours of culture; concentration 
of plastic-adherent and CD34-positive cells after 24 hours of 
culture; n = 7). The SVF on average contains 6.1 × 105 cells 
per mL harvested adipose tissue and an average of 2.6 × 105 
cells per mL tissue was positive for CD34. After 24 hours of cul- 
tivation, an average of 0.8 × 105 cells per mL tissue was plastic 
adherent, and thereof 0.45 × 105 cells per mL tissue, on 
average, were positive for CD34. 
 
a unilocular lipid vacuole that is unstained, due to an 
organelle-inherent lack of esterase activity required for ﬂuo- 
rophore activation. Only a few dead cells were detected 
(Figure 1B, red ﬂuoresecence). Furthermore, blood vessel- 
like structures were detectable throughout the WAL-derived 
tissue (white arrows, Figure 1A and B). Collagenase treat- 
ment of WAL-isolated tissue led to a single cell suspension of 
mostly viable cells (Figure 1C). 
 
Number of Cells in Aspirated Tissue 
After preparation of a single cell suspension, the SVF 
was obtained by removal of adipocytes. The SVF on average 
contained 6.1 × 105 cells per mL aspirated tissue. Almost 
half of that fraction was identiﬁed as CD34 positive (averag- 
ing 43%, about 2.6 × 105 cells per mL aspirated tissue). 
Moreover, an average of 18% of the SVF (0.8 × 105 cells 
per mL aspirated tissue) was adherent after 24 hours of stan- 
dard cell culture, roughly half of this portion was adherent 
and CD34 positive (0.45 × 105 cells per mL aspirated tissue 
from the SVF) (Figure 2). 
 
Proliferation of adMSC In Vitro 
To evaluate the proliferation behavior of WAL-isolated 
adMSC during cultivation and under differentiation 
Figure 3. Proliferation of adMSC under steady state cultivation 
conditions; adMSC were cultured for 35 days. Cell numbers 
were determined at 0, 7, 21, and 35 days. All values were nor- 
malized to the 0 day value. Cells show continuous prolifera- 
tion, ie, 2.5-fold increase of cell number over 35 days of culture 
(n = 8). 
 
 
conditions, cells were seeded into steady state conditions 
and the relative cell numbers were determined after 0, 7, 
21, and 35 days of cultivation. We found a continuous in- 
crease in cell number and thus continuous proliferation of 
adMSC (Figure 3). 
 
Mesenchymal Differentiation Potential 
Adipogenic Differentiation 
After 14 days of adipogenic stimulation, the formation of 
lipid-ﬁlled vacuoles in adMSC was detectable, whereas no 
lipid vacuoles were found in adMSC under control conditions 
(Figure 4A,B). Quantiﬁcation of the amount of accumulated 
intracellular lipid revealed a signiﬁcant 3-fold increase under 
adipogenic differentiation conditions (Figure 4C). 
 
Osteogenic Differentiation 
To evaluate the degree of osteogenic differentiation, the 
activity of the enzyme ALP and the amount of calcium phos- 
phate deposited to the ECM were determined. In contrast to 
the control cultures showing a mild red staining (Figure 5A), 
osteogenically stimulated adMSC showed a distinct red stain- 
ing for ALP after 21 days of cultivation (Figure 5B). After 35 
days of osteogenic stimulation, calcium phosphate deposits 
were found, which was not true for the unstimulated control 
cultures (Figure 5D,E). Quantiﬁcation of these differentiation 
markers conﬁrmed distinct changes in the cellular pheno- 
types: after 21 days in osteogenic differentiation medium, 
cells displayed a more than 4-fold higher activity of ALP than 
cells that had been cultured under standard conditions 
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 Figure 4. Adipogenic differentiation degree of adMSC. Staining of lipid vacuoles (green) and nuclei (blue) in unstimulated control 
cultures (A) and adipogenically stimulated adMSC (AS) after 14 days (B). Quantiﬁcation of lipid content (C, quantiﬁcation of ﬂuo- 
rescence intensity; n = 5; Mann-Whitney U test). Only adipogenically stimulated adMSC showed lipid accumulation. 
 
(Figure 5C). Calcium phosphate deposition by adMSC stimu- 
lated osteogenically for 35 days was almost 100-times higher 
than found for cells in the control cultures, which showed 
almost no calcium phosphate deposition (Figure 5F). 
 
 
DISCUSSION 
WAL is a liposuction procedure that provides a favorable 
aesthetic outcome combined with high tissue protection 
and lower risk of cardiovascular side effects due to lowered 
amount of inﬁltrated ﬂuid compared with conventional li- 
posuction procedures.24,25,35,36 Moreover tissue aspirated 
by WAL has already been successfully applied in grafting 
procedures.26,37 Peltoniemi et al proposed that WAL is a 
preferable technique for autologous fat grafting because it 
yields a transplant rich in stem cells and enables easy injec- 
tion without pressure, thus preventing damage to cells.38 
To conﬁrm the high viability and abundance of stem 
cells in adipose tissue aspirated by WAL, we analyzed WAL 
tissue particles regarding integrity, adMSC yield, and mes- 
enchymal differentiation capacity. The scope of this study 
did not include the examination of other liposuction tech- 
niques, such as a direct comparison of tissue harvested 
from the same patient in the same operation but with 2 dif- 
ferent techniques, which would have been a more direct 
approach for the evaluation of the WAL technique. 
Nonetheless using data from current publications, the WAL 
procedure can be put into context with other liposuction 
techniques. Through visual evaluation, we can show that 
WAL aspiration results in viable tissue with intact 
vasculature-like structures. This is consistent with previous 
ﬁndings revealing that WAL tissue consists of intact cell ag- 
gregates and small blood vessels.35 The assessment of the 
overall cell content and consecutive quantiﬁcation of dead 
and viable cells could be a subject of future studies. We 
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 Figure 5. Osteogenic differentiation degree of adMSC. ALP-staining (red) in control cultures (A) and in osteogenically stimulated 
cultures (OS) after cultivation for 21 days (B). Quantiﬁcation of ALP activity (C; n = 6; Mann-Whitney U test). Staining of ECM 
calcium deposition in control cultures (D) and osteogenically induced cultures after cultivation for 35 days (E). Quantiﬁcation of 
ECM calcium content (F, cresolphthalein staining; n = 4; Mann-Whitney U test). Compared with non-stimulated control cultures, 
osteogenically stimulated cultures showed a 4-fold increase in ALP activity after 21 days and a 100-fold higher calcium deposition 
in the ECM after 35 days. 
 
 
found that the enzymatic digestion procedure yields a 
single cell suspension consisting of adipocytes and an SVF 
with an average of 6.1 × 105 cells per mL WAL tissue. 
Differences in cell number of the SVF have been found 
for different tissue harvesting methods. For example 
an average of 3 × 105 SVF cells per mL tissue was found 
after liposuction not performed by WAL,39 6× 105 after 
ultrasound-assisted liposuction and 7 × 105 after adipose 
tissue resection.40 Since the SVF is a heterogeneous 
mixture of cells and thus the SVF cell content is not a direct 
measure of stem cell content, we have analyzed the pres- 
ence of CD34-positive cells within the SVF. CD34 was ﬁrst 
identiﬁed in stromal precursors in normal human adult 
bone marrow,41 and the Stro-1 antibody frequently used for 
prospective isolation of MSC was consequently generated 
using CD34-positive MSC.42 Subsequently, CD34 was 
found to be expressed also by hematopoietic stem cells in 
activated state and thus cycling in the blood stream, while 
hematopoietic stem cells in quiescent state and residing to 
the bone marrow are CD34 negative.43 Subsequently, the 
panel of CD34-expressing cells was even more extended 
to muscle satellite cells, interstitial cells, epithelial, and 
endothelial progenitors44 and is currently thought to be ex- 
pressed by all perivascular cells in situ,45 though not 
always at constant level, as reported for MSC whose 
CD34-expression level declines upon passaging in vitro.46 
The SVF from WAL tissue contained an average of 
2.6 × 105 CD34-positive cells per mL tissue (an average 
of 43% of SVF). Results from other groups are an average 
of 22.5%17 and 15% to 40% cells per mL tissue.5 Following 
the statements made above, 1 portion of the CD34-positive 
cells is of hematopoietic origin while the other is adMSC. 
This was conﬁrmed by Bourin et al by detecting a 
CD34-positive, but CD45-negative population of cells 
within the SVF of adipose tissue because hematopoietic 
precursors would be positive for both surface markers.20 
The 2 cell populations could be separated by selecting them 
for adherence to standard tissue culture polystyrene 
because adMSC are plastic adherent47 whereas hematopoi- 
etic stem cells are not.48,49 Thus, the CD34-positive and 
plastic-adherent population of 0.45 × 105 cells per mL 
tissue (8% of the SVF and 18.9% of the CD34-positive 
cells) that we isolated from the SVF 24 hours after tissue 
digestion represents a homogenous population of adMSC. 
Other groups have found 6.3% ± 1.8% to be functional 
adMSC residing in the SVF of resected adipose tissue, 
1.9% ± 1.3% functional adMSC in the SVF of tissue 
obtained by tumescent liposuction, and 0.4% ± 0.1% 
functional adMSC in the SVF of tissue obtained by 
ultrasound-assisted liposuction.40 A wide range of adMSC 
8 Aesthetic Surgery Journal 
 
 
content in the SVF is discernible comparing a single 
patient’s material. While the average is 8%, as mentioned 
above, the range varied from 2.3% to 17.9%. Philips et al, 
in experiments where tissue was harvested with the 
Coleman technique, found this range to vary from 4% to 
37%.50 The differences between the study outcomes result 
from the fact that the methods used for the analysis of 
adMSC content in adipose tissue differ between almost 
every single research group. In this case not only the aspira- 
tion method was different but also the adMSC content was 
determined by ﬂow cytometric analysis of the SVF, while in 
our study the absolute adMSC content was determined 
after 24 hours of plastic adherence. 
Supportingly adipogenic stimulation of the isolated 
adMSC led to intracellular lipid accumulation, which 
proves the adipogenic differentiation potential of the 
adMSC obtained from WAL tissue. Also, the osteogenic dif- 
ferentiation potential could be shown after speciﬁc stimula- 
tion by means of differentiation markers ALP activity and 
ECM calciﬁcation. Thus, adMSC from WAL tissue show 
mesenchymal differentiation potential. It has been shown 
that the stem cell content in harvested tissue may be a posi- 
tive measure for the long-term survival and retention of fat 
grafts.50 Thus, not only does WAL represent a very gentle 
operation technique concerning the patient comfort and 
the viability of the harvested tissue,24,38 but the possibility 
of enriching fat grafts with autologous stem cells isolated 
from the same tissue represents a promising clinical appli- 
cation. Another important point will be the future applica- 
tion of stem cells in the treatment of, eg, degenerative 
arthritis, and a possible wide variety of other clinical indica- 
tions. The comparative examination of tissues from the 
same patient harvested by WAL and other liposuction tech- 
niques would be an interesting prospect for future studies. 
 
 
CONCLUSIONS 
WAL is a liposuction procedure that provides favorable 
results concerning patient comfort and aesthetic outcome. 
We show that WAL tissue is a valid source of adMSC, yield- 
ing numbers of cells that lie within the range of cell 
numbers isolatable from adipose tissue harvested with 
other techniques. The adMSC isolated from WAL tissue are 
viable and possess mesenchymal differentiation potential. 
In this respect WAL tissue may be used for autologous fat 
grafting and is an appropriate source for adMSC isolation. 
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A B S T R A C T
Adipose tissue plays a role in energy storage and metabolic balance and is composed of diﬀerent cell types. The
metabolic activity of the tissue itself has been a matter of research for a long time, but comparative data about
the energy metabolism of diﬀerent cell types of human subcutaneous adipose tissue are sparse. Therefore, we
compared the activity of major energy metabolic pathways of adipocytes and CD34+ cells from the stromal
vascular fraction (SVF) separated from the same tissue. This CD34+ cell fraction is enriched with adipose tissue-
derived mesenchymal progenitors, as they account for the largest proportion of CD34+ cells of the SVF.
Adipocytes displayed signiﬁcantly higher mitochondrial enzyme capacities compared to CD34+ SVF-cells, as
shown by the higher activities of isocitrate dehydrogenase and ß-hydroxyacyl-CoA dehydrogenase. Inversely, the
CD34+ SVF-cells showed higher capacities for cytosolic carbohydrate metabolism, represented by the activity of
glycolysis and the pentose phosphate pathway. Thus, the CD34+ SVF-cells may ensure the provision of pentose
phosphates and reduction equivalents for the replication of DNA during proliferation. The data indicate that
these two cell fractions of the human adipose tissue vary in their metabolic conﬁguration adapted to their
physiological demands regarding proliferation and diﬀerentiation in vivo.
1. Introduction
The view of adipose tissue as an organ of mere energy storage has
been amended with its role in the whole body energy balance [1].
Adipose tissue varies in its cellular composition and metabolic task
depending on the developmental stage of the individual and the tissue
source. A distinction can be made between white, brite/beige and
brown adipose tissue. These various adipose tissues diﬀer regarding
speciﬁc energy metabolic characteristics: white adipose tissue stores
and releases energy by turning over lipids [2], whereas brite/beige and
brown adipose tissue dissipates energy directly as heat by uncoupling
oxidative phosphorylation from adenosine triphosphate (ATP) produc-
tion [3,4].
White adipose tissue is composed of a variety of cell types besides
the tissue-characteristic adipocytes. The size and number of adipocytes
in subcutaneous white adipose tissue is highly variable and dependent
on the individual energy balance [5]. All cells of the adipose tissue that
are not adipocytes are called ‘stromal vascular fraction’ (SVF) as they
can be conjointly collected via centrifugation during the technical
process of adipose tissue dissociation and cell isolation. The SVF
includes cells like, adipose tissue-derived mesenchymal stromal cells
(ASC), the progenitors of adipocytes, endothelial cells, and blood-de-
rived cells such as leukocytes and macrophages [6–8]. One large sub-
fraction of the SVF expresses the transmembrane phosphoglycoprotein
CD34 on its surface [6–9]. Relatively little is known about the function
and intracellular ligands of CD34 in the SVF of the adipose tissue
[10,11]. CD34 has been proposed to both promote proliferation and
migration and to block diﬀerentiation [12,13]. In the SVF of adipose
tissue, CD34+ cells include the ASC, the adipocyte progenitor cells, the
endothelial cells and their progenitors, and hematopoietic progenitors
[7,8,11,14]. Approximately 60–85% of the CD34+ SVF- cells are ASC
[15–19].
Earlier examinations of adipose tissue metabolism by enzyme ac-
tivity measurement were carried out on whole adipose tissue homo-
genates [20–23]. In general, enzymes of the glycolytic and related
pathways were examined. The enzyme activities in the total adipose
tissue homogenates indicated a low glycolytic activity since the activ-
ities of the rate-determining enzyme phosphofructokinase (PFK) were
low compared to other tissues like skeletal muscle [20]. Furthermore, a
low capacity for gluconeogenesis was indicated in total adipose tissue
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homogenates due to the comparably low activities of fructose-1,6-bi-
sphosphatase (FBPase) [20,22].
The knowledge about the energy metabolism of cell types separated
from human subcutaneous adipose tissue is limited. Overall adipocytes
are shown to demonstrate a continuous turnover of their stored lipids
[2]. Kheterpal et al. compared energy metabolic aspects of human
adipocytes with the mixed cell population of SVF cells from the same
tissue. They found proteins involved in glycolysis and gluconeogenesis,
lipid metabolism and oxidative stress defense to be diﬀerentially
regulated in adipocytes compared to SVF cells [24].
The quantiﬁcation of enzyme activities can be used for character-
izing the metabolic state of tissues [25,26]. Therefore, in this study we
have analyzed and compared marker enzyme activities of major energy
metabolic pathways of human adipocytes with those of the CD34+ cell
population from SVF which is enriched in ASC content. Thus, we
compared marker enzyme activities of mature adipocytes with those of
an enriched fraction of adipose tissue-derived mesenchymal progeni-
tors. Since the isolation of these cell fractions took place without further
cell cultivation, these enzyme activities had not been inﬂuenced by in
vitro conditions.
2. Materials and methods
2.1. Tissue donation
The study was approved by the ethics committee of Rostock
University Medical Center [http://www.ethik.med.uni-rostock.de/],
registration number A2013-0112 and it complies with the ethical
standards deﬁned by the World Medical Association Declaration of
Helsinki. The patients gave informed consent for the use of their tissue
in a scientiﬁc study.
Material from 8 patients was used for this study. Three of these
patients were male, ﬁve female. The patients were on average 44 years
old (ranging from 18 to 65) and had an average BMI of 29.5 (ranging
from 25.9 to 34.4) and were thus mildly obese but not diabetic.
2.2. Collection of CD34+ SVF-cells and adipocytes
The adipose tissue was attained by liposuction either using a tu-
mescent or a water-jet assisted procedure. The time between the tissue
harvest and the cell isolation was between 3 and 20 h. During this time,
the tissue was stored at room temperature. The digestion of two times
30ml of adipose tissue was based on a previously established isolation
protocol [27]; each of the 30ml tissue portions were exposed to a di-
gestion with an end concentration of 0.12 U/ml collagenase (NB4,
Serva). Incubation took place for 30min, shaking at 37 °C. After ﬁl-
tration through a 100 μm strainer (Greiner), the digested tissue was
washed with 10ml Ringer solution (B. Braun Melsungen) with 4%
human albumin (Behring). After 10min of sedimentation the tissue was
centrifuged for 10min at 400× g at room temperature. After cen-
trifugation the lipid portion of the tissue consisted of an oily phase on
top and a phase with single cell adipocytes relieved from cells of the
SVF below. 1ml of single cell adipocyte suspension was taken and
shock frozen in liquid nitrogen. The samples were stored at −80 °C
until the measurement of the enzyme activities.
The rest of the supernatant was discarded. The cell pellets were each
resuspended in 10ml Ringer solution with 4% human albumin, ﬁltered
through a 40 μm strainer and again centrifuged for 10min at 400× g at
room temperature. The cell pellets of both 30ml tissue portions were
then pooled in 10ml Dulbecco's Modiﬁed Eagle Medium (DMEM,
Thermo Fisher Scientiﬁc) containing 10% FCS and antibiotics (100 U/
ml penicillin, 100mg/ml streptomycin, Thermo Fisher Scientiﬁc). After
the addition of 80 μl magnetic Dynabeads™ from the CD34 positive
Isolation Kit (Thermo Fisher Scientiﬁc) the cells were incubated on a
roll mixer at 4 °C for 30min. The cells were then attached to a magnet.
After the removal of cell culture medium, the cells were resuspended in
10ml Ringer solution with 4% human albumin. After 10min of
washing on the roll mixer at 4 °C, the cells were again attached to the
magnet and ﬁnally resuspended in 1.5ml of sodium phosphate buﬀer
(100mM Na2HPO4, 100mM NaH2PO4, 1mM EDTA, 1mM DTT, 1mM
PMSF). 1 ml of cell suspension was shock frozen in liquid nitrogen. The
samples were stored at −80 °C until the measurement of the enzyme
activities.
2.3. Preparation of adipocytes for enzyme activity measurement
The 1ml adipocyte fractions were thawed on ice, and 500 μl of
sodium phosphate buﬀer and 1 μl of 100mM PMSF (Applichem) were
added (ﬁnal PMSF concentration: 66.7 μM). The adipocyte fractions
were disintegrated on ice via ultrasonication with a Branson soniﬁer
(3×10 s, duty cycle constant, level 1, Heinemann Ultraschall-und
Labortechnik). The disintegrated adipocyte solutions were then cen-
trifuged at 10,000× g for 6min at 4 °C. The aqueous infranatant was
used for the measurement of the enzyme activities.
2.4. Preparation of CD34+ SVF-cells for enzyme activity measurement
The 1ml CD34+ SVF fractions were thawed on ice and 1 μl of
100mM PMSF were added. The cells were disintegrated on ice via ul-
trasonication with a Branson soniﬁer for 3×10 s, duty cycle constant,
level 1. The solutions with the entirely disintegrated cells were then
centrifuged at 400× g for 5min at 4 °C. The supernatant was used for
the measurement of the enzyme activities.
2.5. Enzyme activity measurement
Enzyme assays were performed with aliquots of the cell homo-
genates. The enzyme activities were traced spectrophotometrically in a
microplate reader (TECAN), measuring the light absorption at 340 nm
(37 °C) using NAD(P)H + H+ as indicator. The activities were given as
international units per mg DNA (1 U=1 μmol substrate transformed
per min at 37 °C). The assays for phosphofructokinase (PFK; EC
2.7.1.11), glyceraldehyde 3-phosphate dehydrogenase (GAPDH, EC
1.2.1.12), lactate dehydrogenase (LDH; EC 1.1.1.27), glucose 6-phos-
phate dehydrogenase (G6PDH, EC 1.1.1.49), fructose-1,6-bispho-
sphatase (FBPase, EC 3.1.3.11), glutathione disulﬁde reductase (GSR;
EC 1.8.1.7), NAD+-dependent isocitrate dehydrogenase (NAD-IDH; EC
1.1.1.41), NADP+-dependent isocitrate dehydrogenase (NADP-IDH; EC
1.1.1.42), ß-hydroxyacyl-CoA dehydrogenase (HOADH; EC 1.1.1.35)
and creatine kinase (CK; EC 2.7.3.2) were performed as previously
described [28].
2.6. Determination of DNA content
The Qubit™ dsDNA BR Assay Kit and the Qubit® 2.0 Fluorometer
(Thermo Fisher Scientiﬁc) were used according to the manufacturer's
instructions to determine the DNA content in the homogenates. The
Qubit™ dsDNA BR Assay Kit detects double-stranded DNA.
2.7. Flow cytometry
The isolated SVF was immediately analyzed via the Stem-Kit™
Reagents test kit (Beckman Coulter). The kit includes the CD45-FITC
(clone J33)/CD34-PE (clone 581) Reagent (CD45/CD34), the CD45-
FITC/IsoClonic Control-PE Reagent, Stem-Count Fluorospheres, 7AAD
Viability dye and 10× NH4Cl Lysing solution. Staining was done ac-
cording to the manufacturer's instructions. For the quantiﬁcation of the
amount of nucleated cells, Hoechst 33342 was added in a concentration
of 5 μg/ml 10min before measuring. First the analyzed cell solution was
gated on Hoechst-positive and thus nucleated cells. The nucleated cells
were further gated on CD34+CD45− and CD34+CD45+ cells. Viability
of cells was assessed by 7-AAD staining. The data were acquired with a
J. Meyer, et al. Experimental Cell Research 380 (2019) 47–54
48
FACS Aria II machine (BD Biosciences, Germany) and analyzed using
FACS Diva Software (Version 6.1.2).
2.8. Fluorescent staining
All staining solutions were prepared in cell culture medium (see
2.2). The staining of the adipose tissue and adipocytes was performed
with Calcein AM (5 μg/ml, ABD Biosciences) and Hoechst 33342 (5 μg/
ml, Sigma-Aldrich). After 10min of incubation in the dark under cau-
tious agitation, ﬂuorescence microscopy images were acquired using an
Axiocam MRc ﬁtted to an Axio Scope.A1 (Carl Zeiss).
The staining of the SVF and the CD34+ SVF-cells was performed
after centrifugation of the cells at 400× g. The resulting cell pellet was
resuspended in the staining solution containing Calcein-AM and
Hoechst 33342 in a concentration of 5 μg/ml each. After 10min of in-
cubation in the dark, the images were obtained as described above.
2.9. Statistical analysis
The numbers of donors are included in the ﬁgure and table legends.
Excel 2013 and R software environment (version 3.3.1) for statistical
computing and graphics [29] were used for calculations and statistical
analysis (homogeneity of variances for the enzyme activity data, U test
according to Mann and Whitney (p < 0.05)). The graphs were gener-
ated with GraphPad Prism version 7.02 for Windows (GraphPad Soft-
ware) and display medians and the interquartile range.
3. Results
3.1. Processing of the human lipoaspirate and characterization of the
resulting cell types after tissue dissociation
The processing of the human adipose tissue and the isolation of the
two cell fractions was as follows (schematically depicted in Fig. 1I):
Aspirated adipose tissue which consists of small lobules (Fig. 1I, top)
was subjected to an enzymatic dissociation which led to a single-cell
suspension. After steps of washing, ﬁltration and centrifugation the
lipid phase was separated from the aqueous phase, leading to the two
populations of adipocytes and the SVF (Fig. 1I, middle). By means of a
magnetic bead system, the CD34+ fraction was separated from the re-
mainder of the SVF (Fig. 1I, bottom).
These diﬀerent steps of the processing and cell separation were
traced microscopically (Fig. 1II). The aspirated human liposuction
tissue consists of small lobules and showed large adipocytes ﬁlled with
a monolocular lipid vacuole. The adipocytes were embedded in a vas-
cularized tissue structure (Fig. 1IIA). After enzymatic dissociation, the
cells from the lipid phase of the preparation were recognizable as adi-
pocytes in suspension due to their monolocular vacuole (Fig. 1IIB). The
lipid phase was void of further tissue structures and non-adipocytic
cells. Surrounding lipid droplets could be distinguished from the adi-
pocytes by the lack of a nucleus (Fig. 1IIB). The cells of the aqueous
phase of the adipose tissue preparation were a mixture of single cells of
diverse morphology, deﬁned as the SVF cells. The SVF fraction is free of
adipocytes due to the fractionation of the lipid and aqueous phase
(Fig. 1IIC). The following CD34 magnetic bead selection resulted in a
CD34+ fraction of the SVF (named CD34+ SVF-cells) (Fig. 1IID and E).
Flow cytometry revealed that 36.9% of the isolated SVF cells were
CD34+ (Fig. 2). Within the SVF population only 0.9% of the cells were
positive for CD34 as well as for CD45. Thus, within the CD34+ SVF,
97.6% of the cells were CD45-negative.
3.2. Analysis of maximum catalytic capacities of major energy metabolic
pathways
Important energy-metabolic pathways were examined by measuring
the maximum catalytic activities of several marker enzymes in freshly
isolated adipocytes and the CD34+ SVF-cells of the SVF from the same
adipose tissue (Fig. 3). These analyses revealed that the rate-limiting
enzyme of glycolysis, the phosphofructokinase (PFK), is detectable in
low activities in adipocytes (0.21 U/mg DNA), whereas CD34+ SVF-
cells showed 4.5-fold higher PFK-activities (0.95 U/mg DNA) (Fig. 3A).
The glycolytic enzymes glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) and lactate dehydrogenase (LDH) displayed the highest ac-
tivities in both cell populations (Fig. 3B and C). The GAPDH activity
was, with 10.8 U/mg DNA, approximately 1.7-fold higher in adipocytes
than in the CD34+ SVF-cells (6.37 U/mg DNA). The LDH activity in
adipocytes was, with 25.3 U/mg DNA, approximately 2.3-fold higher
than in the CD34+ SVF-cells (6.37 U/mg DNA).
The activity of the marker enzyme of the pentose phosphate
pathway, the glucose-6-phosphate dehydrogenase (G6PDH), was over
5-fold less in adipocytes (0.19 U/mg DNA) compared with the CD34+
SVF-cells at 0.98 U/mg DNA (Fig. 3D).
A marker enzyme of the gluconeogenesis, the fructose 1.6-bispho-
sphatase (FBPase), was represented in low activities in both cell po-
pulations: the activity of FBPase was, with 0.04 U/mg DNA, 4-fold
higher in adipocytes than in the CD34+ SVF-cells with 0.01 U/mg DNA
(Fig. 3E).
The antioxidant defense enzyme glutathione reductase (GSR)
showed nearly similar activities in adipocytes and the CD34+ SVF-cells
(0.65 U/mg DNA in adipocytes and 0.58 U/mg DNA in CD34+ cells)
(Fig. 3F).
The enzymes NAD+-dependent isocitrate dehydrogenase (NAD-
IDH), NADP+-dependent isocitrate dehydrogenase (NADP-IDH) and ß-
hydroxyacyl-CoA dehydrogenase (HOADH) are connected to oxygen-
dependent energy metabolism which is located in the mitochondria.
These enzymes showed signiﬁcantly higher activities in adipocytes than
in the CD34+ SVF-cells. The activity of the NAD-IDH was, with 0.44 U/
mg DNA, 3.1-fold higher in adipocytes compared with the CD34+ SVF-
cells with 0.14 U/mg DNA. The activity of the NADP-IDH with 1.63 U/
mg DNA was 2.6-fold higher in adipocytes than in the CD34+ SVF-cells
with 0.63 U/mg DNA. The activity of the HOADH with 4.93 U/mg DNA
in adipocytes was 5.4-fold higher than in the CD34+ SVF-cells with
0.92 U/mg DNA (Fig. 3G, H and I).
The phosphocreatine/creatine kinase reaction is part of the energy
metabolism of many cell types and can work without oxygen. The ac-
tivity of the creatine kinase (CK) was 2.8-fold higher in adipocytes with
5.11 U/mg DNA compared with the CD34+ SVF-cells with 1.82 U/mg
DNA (Fig. 3J).
4. Discussion
Mature adipocytes have been demonstrated to execute a continuous
turnover of their stored lipids [2] and are considered to be incapable of
proliferation [30]. In contrast, a majority of the CD34+ SVF-cells have a
precursor status and are potentially able to proliferate and diﬀerentiate
depending on their physiological needs [30–33]. Therefore, adipocytes
and CD34+ SVF-cells face diﬀerent physiological demands that might
be reﬂected in their metabolic capacities.
4.1. Preparation of adipocytes and CD34+ SVF-cells
The isolation of adipocytes and the SVF is well-established [34,35].
We have extended a known isolation protocol by a magnetic bead-based
isolation of a CD34+ SVF-cell population. Our ﬂow cytometric data
revealed that 36.9% of the nucleated cell fraction was positive for
CD34. The CD34+ SVF-cell population includes endothelial cells, en-
dothelial progenitors, hematopoietic progenitors the ASC and the adi-
pocyte progenitors [11,14]. Between 13.3% and 15.4% of the cells in
the SVF were found to be CD45-/CD34+ and positive for CD31 as well.
These cells are considered to be mature endothelial cells and en-
dothelial progenitors [18,19]. According to our data only 0.9% of the
nucleated SVF cells co-expressed CD45 and CD34 and may thus be
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considered hematopoietic precursors [36]. Other studies have found
2–4% of the SVF cells to co-express CD34 and CD45 [37,38]. From our
data and the literature, we can thus conclude that approximately
60–85% of the cells isolated with the CD34+-selection used in this
study were ASC [15–19].
4.2. Diﬀerences in the energy metabolic conﬁguration of the cell populations
separated from human adipose tissue.
4.2.1. Glycolysis and gluconeogenesis
The activities of the glycolysis-related enzymes PFK, GAPDH and
LDH could be detected in both cell populations, and thus indicate the
capacity for glycolysis [20,39]. GAPDH and LDH activities were sig-
niﬁcantly higher than PFK in both cell populations. This is in agreement
with Shonk et al. who detected PFK, GAPDH and LDH activities in
Fig. 1. I: Schematic depiction of the adipose tissue processing and II: microscopic depiction of the tissue and cell fractions during processing by combined
vital and nuclear staining and phase contrast. A) Aspirated adipose tissue, (B) adipocytes from the lipid phase of the tissue preparation, (C) SVF after separation,
(D) phase contrast micrograph of CD34+ SVF-cells, (E) vital/nuclear stain of the CD34+ SVF-cells from the SVF (green: vital stain, blue: nuclei, scale bar= 100 μm in
A and B; 50 μm in C, D and E). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
Fig. 2. Flow cytometry of freshly isolated SVF cells. Representative plots of A) nucleated cells, B) nucleated cells gated on CD34+CD45− and CD34+CD45+ and
C) isotype control. Numbers in the dot plots indicate the mean percentages of the particular cell populations (n= 4).
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Fig. 3. Marker enzyme activities in adipocytes and the CD34+ SVF-cells; (A) PFK; (B) GAPDH; (C) LDH; (D) G6PDH; (E) FBPase; (F) GSR; (G) NAD-IDH; (H)
NADP-IDH; (I) HOADH and (J) CK; activities were normalized to the overall DNA content of the cells (n = 4 *signiﬁcantly diﬀerent; Mann-Whitney U Test,
p < 0.05).
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human whole adipose tissue homogenates [22]. The proportions of the
glycolysis-related enzymes diﬀer clearly between the examined cell
populations: Whereas the GAPDH and LDH activities were approxi-
mately twice as high in adipocytes, the activities of PFK were ap-
proximately four times lower in adipocytes compared to the CD34+
SVF-cells.
PFK catalyzes the ﬂux-determining, the non-equilibrium reaction of
glycolysis, while the reaction catalyzed by GAPDH happens at near
equilibrium [25]. The inverse behavior of PFK and GAPDH appears
contradictory since both enzymes are part of the same pathway. Com-
parative studies of adipocytes and the mixed SVF revealed contra-
dictory results as well: Kheterpal et al. found a higher GAPDH protein
amount in adipocytes compared with the SVF, but simultaneously lower
protein amounts of triosephosphate isomerase [24]. Both enzymes are
part of the glycolytic pathway. One explanation for this inverse beha-
vior could be anaplerosis of the glycolytic pathway from glycerol. In
this context the substrate of GAPDH, i.e. 3-phosphoglyceraldehyde,
might not only emerge from the PFK product fructose-1,6-bisphosphate,
but also from glycerol by the activities of the enzymes glycerol kinase,
glycerol-3-phosphate dehydrogenase and triose phosphate isomerase
[40], which can each be found in white adipose tissue or adipocytes
respectively [24,41–43].
Glycolytic metabolism is thought to be increased in actively pro-
liferating cells [44]. In contrast to adipocytes, CD34+ SVF-cells have
been identiﬁed to possess proliferative potential [2]. ASC in vitro that do
not proliferate displayed a decrease in glycolytic capacity, whereas the
highly proliferative ASC displayed an increase in glycolytic capacity
[28].
Among the analyzed enzymes, the marker enzyme of gluconeo-
genesis, FBPase, showed the lowest capacities. In contrast, in ASC in
vitro the FBPase activities were below the detection limits [28]. This
diﬀerence could represent an adaptation to the in vitro conditions with
plentiful glucose available. The culture medium used in this study
contains 4.5 g/l glucose, which is about 4-fold higher than the normal
blood glucose level [45]. Thus, it can be suggested the gluconeogenic
capacity is downregulated in vitro since the necessity for glucose re-
covery becomes obsolete. Therefore, it is suggested that in vivo adipo-
cytes and ASC from the same tissue possess a metabolic ﬂexibility to be
able to facilitate gluconeogenesis when needed.
4.2.2. Pentose phosphate pathway
A pathway branching oﬀ intermediate products from glycolysis is
the pentose phosphate pathway [46]. Its rate-limiting marker enzyme is
the G6PDH. In our study the measured activities of PFK and G6PDH
suggest a similar capacity for the pentose phosphate pathway and
glycolysis. The pentose phosphate pathway delivers pentoses for RNA
or DNA synthesis and NADPH for the cytosolic regeneration of glu-
tathione, protecting the redox status [40]. High G6PDH activity has
been associated with increased proliferation of various cell lines in vitro
[47]. The low G6PDH activity described in this study for adipocytes
that do not proliferate substantially [48], compared with CD34+ SVF-
cells, conﬁrms these observations.
4.2.3. Mitochondria-related metabolism
The enzymes involved in mitochondrial metabolism showed sig-
niﬁcantly higher activities in adipocytes than in CD34+ SVF-cells, in-
dicating a distinguished role of mitochondrial and lipid metabolism
respectively in diﬀerentiated human adipocytes. While mitochondrial
proteins represent only 4.8% of the total human proteome in adipocytes
[49], 22% of the proteins were identiﬁed as of mitochondrial origin
[50]. In this study, the signiﬁcance of the mitochondrial metabolism in
adipocytes becomes evident by the measured capacity of the NAD-IDH,
which is 3-fold higher when compared with the capacity measured in
CD34+ SVF-cells.
The most striking diﬀerence in activity was obvious for HOADH, the
enzyme indicating the capacity for β-oxidation, which was about 5-fold
higher in adipocytes. Fain et al. described an enrichment of mRNAs
encoding enzymes involved in the turnover of lipids in adipocytes when
compared with the SVF of human omental adipose tissue [51]. Inter-
estingly, when comparing the capacities of HOADH in in vitro-cultured
ASC with and without adipogenic stimulation, we observed the same
behavior [28].
In mitochondria, the NADP-IDH plays a major role for the NADPH
supply for the antioxidative defense catalyzed by the GSR [52]. Since
no diﬀerence was measured in GSR activity, the higher activity mea-
sured for NADP-IDH in adipocytes might originate from the cytosolic
isoform that delivers reduction equivalents for lipid synthesis [52]. The
comparatively low NADP-IDH activities measured in CD34+ SVF-cells
which do not synthesize lipids in substantial amounts indicate a low
demand for glutathione regeneration and thus a low need for anti-
oxidative defense. However, the antioxidative defense system is com-
plex, so this issue needs further investigation.
4.2.4. Phosphocreatine system
The CK catalyzes a near-equilibrium reaction and is found in cyto-
plasm and mitochondria (reviewed in Ref. [53]). The CK activity in
adipocytes was almost three times higher than in CD34+ SVF-cells. In
adipocytes of white adipose tissue, the CK activity cannot be linked to a
role in thermogenesis as it is done in brown adipocytes [54]. Thus the
following scenario could be possible: the CK activity in the adipocytes
might be facilitated to overcome the limitation of a strictly diﬀusional
exchange of ATP and ADP among gradients and thus spatial restrictions
of energy transport [55]. The main volume of adipocytes is occupied by
a monolocular lipid vacuole that is encompassed by a thin layer of
cytoplasm. It appears thus likely that CK ensures the subcellular ATP
homeostasis, improving energy transport from ATP-producing to ATP-
consuming reactions [56]. When comparing the capacities of CK in in
vitro-cultured ASC with and without adipogenic stimulation, we found
the similar behavior [28].
4.2.5. Overall view of energy metabolic characteristics
In principle, the diﬀerences in the methods of isolation and pre-
paration as well as analysis of the cell populations discussed in this
study might lead to limitations regarding the comparability and inter-
pretation of results. Further examinations will be necessary to illumi-
nate the metabolism of the diﬀerent cell types of adipose tissue.
Interestingly, the statistical deviations of the data collected for adipo-
cytes were overall higher than those found for the relatively hetero-
geneous CD34+ SVF-cell population. These deviations might be of in-
terest, since the adipocyte amount and diﬀerentiation degree is
dependent on the nutritional state of the donor [57]. Thus, for future
experiments it will be of interest to pay also attention to speciﬁc patient
parameters like body mass index.
In conclusion, we found considerable diﬀerences in the metabolic
phenotype of adipocytes and CD34+ SVF-cells from the same tissue.
The enzymes related to mitochondrial and lipid metabolism showed a
higher representation in adipocytes, whereas the activity of the rate-
limiting enzyme of glycolysis was higher in the CD34+ SVF-cells. These
energy metabolic diﬀerences can be interpreted as an adaptation to
their physiological demands and might correlate with the potential of
CD34+ SVF-cells to be able to proliferate and diﬀerentiate, whereas
adipocytes do not proliferate after ﬁnal diﬀerentiation. These data
might allow conclusions regarding the distinct physiological demands
of diﬀerentiated adipocytes and the CD34+ SVF-cells in the human
adipose tissue in vivo.
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A B S T R A C T
Mesenchymal stromal/stem cells (MSC) are important in tissue homeostasis and regeneration due to their ability
for self-renewal and multipotent diﬀerentiation. Diﬀerentiation, as well as proliferation, requires adaptations in
the cell metabolism. However, only few data exist concerning the energy metabolism of non-diﬀerentiating and
diﬀerentiating MSC. In this study we compared capacities of major energy metabolic pathways of MSC from
human adipose tissue (adMSC) in vitro in the non-diﬀerentiated state with those of osteogenically or adipo-
genically diﬀerentiating adMSC. To this end we quantiﬁed the proliferation and diﬀerentiation status of adMSC
and analyzed maximum enzyme capacities and several enzyme isoforms of major energy metabolic pathways
regarding their activity and gene expression. We could show that non-diﬀerentiating and osteogenic cultivation
conditions induced proliferation and showed increasing capacities of the glycolytic marker enzyme phospho-
fructokinase as well as the marker enzyme of the pentose phosphate pathway glucose-6-phosphate dehy-
drogenase. Adipogenic stimulation, which was accompanied by the absence of proliferation, reduced the gly-
colytic capacity (e.g. decreased glyceraldehyde 3-phosphate dehydrogenase capacity) and induced an increase in
mitochondrial enzyme capacities. These changes in energy metabolism might represent an adaptation of adMSC
to the high energy demand during proliferation and to the speciﬁc cellular functions during osteogenic or
adipogenic diﬀerentiation respectively.
1. Introduction
Mesenchymal stromal/stem cells (MSC) from human adipose tissue
(adipose-derived MSC/adMSC) have gained increasing attention for
therapeutic applications as a possible alternative to other stem cell
types like bone marrow MSC (bmMSC) [1–3]. Zuk et al. were the ﬁrst to
characterize adMSC [4,5]. adMSC are important in tissue homeostasis
and regeneration due to their capacity for self-renewal and multipotent
diﬀerentiation [6]. adMSC have been shown to possess potential for
mesenchymal (e.g. adipocytes, osteocytes, chondrocytes in vitro) [4,5]
and non-mesenchymal (e.g. neuron-like morphology) [7] diﬀerentia-
tion. It has been suggested that the number of MSC in adipose tissue is
higher than in bone marrow [8]. The feasibility and safety of ther-
apeutic applications of adMSC have been examined in animals and
humans [9–11].
The energy and substrates for biosynthesis are provided by the
cellular metabolism. Enzymes and metabolites of the cellular
metabolism participate in cell signaling and gene expression [12–14].
Cell fates such as diﬀerentiation and proliferation can cause changes in
metabolism and can also be dependent on them [15,16]. Diﬀerent cells
show varying demands on energy supply, dependent on their function
and environment [17,18]. Short-term changes in energy demand re-
quire adaptation within seconds (e.g. in the active muscle). This can be
realized by modiﬁcations of regulatory enzymes. The modiﬁcations can
be of a covalent (e.g. phosphorylation) or non-covalent nature (allos-
teric regulation). Long term adaptations of energy metabolism to spe-
ciﬁc environments or cell functions are indicated by changes of enzyme
concentrations [19]. The participation of diﬀerent metabolic pathways
in energy metabolism can be assessed by measuring the maximum ac-
tivities of marker enzymes which catalyze irreversible or ﬂux-limiting
reactions of the respective pathways [20,21].
Only few data concerning the energy metabolism of MSC in vitro
have been published so far. It has been shown that bmMSC mainly
metabolize glucose to lactate (glycolysis), rather than using oxidative
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T
phosphorylation [22]. Furthermore it has been demonstrated that non-
diﬀerentiating bmMSC and osteogenically diﬀerentiating bmMSC ex-
hibit a mixed metabolism, with a signiﬁcant glycolytic component [23].
The diﬀerentiation of MSC is shown to be regulated by mitochondrial
function [24,25].
Since it is known that MSC show variations in their proliferation
behavior and phenotype depending on their diﬀerentiation status, we
hypothesized that the process of diﬀerentiation in adMSC is accom-
panied by diverging energy demands. These divergences might induce
diﬀerences in their energy metabolism. To support this hypothesis, we
analyzed major metabolic pathway capacities in undiﬀerentiated and
diﬀerentiating adMSC. With these new data we were able to reveal
fundamental energy metabolic characteristics of adMSC and their
adaptations during osteogenic and adipogenic diﬀerentiation.
2. Materials and methods
Unless stated otherwise, the chemicals, enzymes, antibiotics and
biological factors were supplied by Sigma-Aldrich. Cell culture plastics
were from Nunc and Greiner.
2.1. Tissue donation
The patients gave informed consent to a donation of their tissue. The
study was approved by the ethics committee of the Rostock University
Medical Center [http://www.ethik.med.uni-rostock.de/] under the re-
gistration number A2013-0112. It complies with the ethical standards
of the World Medical Association Declaration of Helsinki.
The material for the diﬀerent analyses was retrieved from 15 pa-
tients. The data, as supplied by the surgeons, show 1 male and 14 fe-
male patients. The patients were on average 41.8 years old (ranging
from 29 to 54) and had a BMI of 24.2 (ranging from 19.5 to 27.4); this
corresponds to a normal average weight. The liposuction procedure was
performed by the water-jet assisted liposuction or tumescent suction
technique.
2.2. Isolation and culture of adMSC
adMSC isolation was performed as previously described [26] with
some variations. Brieﬂy, the tissue was digested for 30min, shaken with
Collagenase (SERVA) dissolved in PBS (with Ca2+ and Mg2+, PAN
Biotech) at a concentration of 0.24 U/mL. The tissue was ﬁltered
through a 100 µm strainer (BD) and washed with 10mL of PBS con-
taining 10% fetal calf serum (FCS, PAN Biotech). After a sedimentation
time of 10min, the infranatant was ﬁltered through a 40 µm strainer
(BD). After centrifugation for 10min at 400× g, the pellets were
pooled in 10mL PBS containing 10% FCS and centrifuged for 5min at
400× g. The ﬁnal cell pellet was then resuspended in 12mL Dulbecco's
Modiﬁed Eagle Medium (DMEM, 4.5 g/L glucose, 0.862 g/L glutamine;
Thermo Fisher Scientiﬁc) containing 10% FCS and antibiotics (100 U/
ml penicillin, 100mg/mL streptomycin, Thermo Fisher Scientiﬁc)
(hereinafter called proliferation medium), seeded into 75 cm2 cell cul-
ture ﬂasks and cultivated at 37 °C and 5% CO2 in a humidiﬁed atmo-
sphere. This selection for plastic adherent cells after 24 h of incubation
was amended by a selection of a CD34-positive subpopulation with the
Dynal CD34 progenitor cell isolation system (Thermo Fisher Scientiﬁc).
The cells so attained were declared as the passage 1 culture.
Seeding of the cells for experimentation was done in the fourth
passage at 20,000 cells/cm2 into 6- and 96-well plates. After seeding,
adMSC were cultured until conﬂuence was reached (2–3 d) and then
stimulated to diﬀerentiate using an osteogenic diﬀerentiation stimu-
lating medium (OS: proliferation medium plus 0.25 g/L ascorbic acid,
1 μM dexamethasone and 10mM β-glycerophosphate) or adipogenic
diﬀerentiation stimulating medium (AS: proliferation medium plus
1 μM dexamethasone, 500 μM IBMX, 200 μM indomethacin, 10 μM in-
sulin). US indicates the proliferation medium only containing 1%
penicillin/streptomycin and 10% FCS and no speciﬁc diﬀerentiation
factors; this was used for the non-stimulated adMSC cultures. The start
of stimulation is termed day zero of experimentation.
2.3. Cell number quantiﬁcation
Quantiﬁcation of the adMSC number under the distinct experi-
mental conditions was done indirectly using the basic dye crystal violet.
Due to its positive charge, crystal violet binds negatively charged cel-
lular macromolecules, most of which consist of DNA, via ionic attrac-
tion [27]. Due to a linear correlation, cell numbers can indirectly be
determined quantifying the optical density (OD) of the re-solubilized
dye [28]. The staining was done according to a previously established
protocol [29].
2.4. Detection of diﬀerentiation
Microscopic depiction of osteogenic diﬀerentiation – Osteogenic
diﬀerentiation was visualized by the staining of the alkaline phospha-
tase (ALP) activity after 21 days (using Naphtol AS-MX phosphate and
Fast Red Violet LB); staining of the extracellular matrix mineralization
was performed after 35 days (using alizarin red S). Both protocols were
described previously [30]. The images were recorded with an AxioCam
ICc1 camera ﬁtted to an Axiovert 25 (Carl Zeiss Microscopy GmbH).
Quantiﬁcation of alkaline phosphatase activity – Osteogenic dif-
ferentiation was analyzed by the quantiﬁcation of ALP. ALP catalyzes
the hydrolysis of an arylphosphate residue of its synthetic substrate
para-nitrophenyl phosphate (pNPP) into the colored product para-
nitrophenol [31]. Quantiﬁcation the optical density of the colored
product generated over time yields a measurement of ALP activity. The
staining was done according to a previously established protocol [29].
Microscopic depiction and quantiﬁcation of cellular lipid content –
Cellular lipid content was determined using an unmodiﬁed lipophilic
boron dipyromethene dye (Bodipy) which dissolves well in cellular
neutral lipids ̶most of which are triglycerides ̶ which form the core of
lipid droplets and are surrounded by a monolayer of phospholipids
[32]. The staining and analysis was done according to a previously
established protocol [30]. The ﬂuorescence intensity within the cells is
measured in relative ﬂuorescence units (RFU). Fluorescence microscopy
was performed using an Axiocam MRc ﬁtted to an Axio Scope.A1 (Carl
Zeiss Microscopy GmbH).
2.5. Enzyme activity assays
The adMSC layers were washed once with PBS, and afterwards
85 µL/cm2 extraction buﬀer (100mM Na2HPO4 (Merck), 100mM
NaH2PO4 (Merck), 1 mM dithiothreitol (Roche), 1 mM ethylenediami-
netetraacetic acid (EDTA), 0.1 mM Phenylmethylsulfonyl ﬂuoride
(PMSF, Applichem)) was added. Subsequently, the cell layers were
mechanically detached with a cell scraper (Sarstedt). The resulting cell
suspension was frozen in liquid nitrogen and stored at− 80 °C. For the
enzyme activity assays, the frozen cell suspension was slowly thawed.
0,1 mM PMSF was added and the suspension was homogenized with a
soniﬁer (3×10 s, at 4 °C, G. Heinemann Ultraschall-und Labortechnik).
Enzyme assays were performed with aliquots of adMSC homogenates.
The enzyme activities were measured in a microplate reader (TECAN),
tracing the light absorption at 340 nm (37 °C) with NAD(P)H +H+ as
indicator. The activities are displayed as international units per mg
DNA (1 U = 1 µmol substrate transformed per min at 37 °C). The assays
for phosphofructokinase (PFK; EC 2.7.1.11), lactate dehydrogenase
(LDH; EC 1.1.1.27), NAD+-dependent isocitrate dehydrogenase (NAD-
IDH; EC 1.1.1.41), NADP+-dependent isocitrate dehydrogenase (NADP-
IDH; EC 1.1.1.42) and glutathione disulﬁde reductase (GSR; EC 1.8.1.7)
have been described [33] and were adapted as described in Peters et al.
[34]. The following assays were further modiﬁed:
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12):
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50mmol L−1 triethanolamine buﬀer (TRAP), 4 mmol L−1 MgCl2
(Merck, Darmstadt, Germany), 1 mmol L−1 ATP (Roche, Mannheim,
Germany), 1 mmol L−1 EDTA, 2.4mmol L−1 glutathione, 7 mmol L−1
3-phosphoglycerate, 0.2mmol L−1 NADH +H+, 10 UmL−1 phos-
phoglycerate kinase (EC 2.7.2.3); pH 7.6.
ß-Hydroxyacyl-CoA dehydrogenase (HOADH; EC 1.1.1.35):
100mmol L−1 triethanolamine buﬀer (TRAP), 5 mmol L−1 EDTA,
0.2 mmol L−1 NADH +H+; 0,3mmol L−1 acetoacetyl coenzyme A, pH
7.6.
Creatine kinase (CK; EC 2.7.3.2): 100mmol L−1 triethanolamine
buﬀer (TRAP), 8 mmol L−1 MgCl2, 2 mmol L−1 EDTA, 1mmol L−1
ADP, 25 µmol L−1 diadenosine pentaphosphate, 30mmol L−1 phos-
phocreatine, 2 mmol L−1 NADP+, 20mmol L−1 glucose, 2 UmL−1
glucose 6-phosphate dehydrogenase (G6PDH, EC 1.1.1.49), 3 UmL−1
hexokinase (HK, EC 2.7.1.1); pH 7.6.
Glucose 6-phosphate dehydrogenase (G6PDH, EC 1.1.1.49):
50 mmol L−1 triethanolamine buﬀer (TRAP), 5 mmol L−1 EDTA,
0.4 mmol L−1 NADP+, 2mmol L−1 glucose 6-phosphate; pH 7.6.
Fructose-1,6-bisphosphatase (FBPase, EC 3.1.3.11): 100mmol L−1
triethanolamine buﬀer (TRAP), 5 mmol L−1 EDTA, 80mmol L−1 MgCl2,
0.4 mmol L−1 fructose 1,6-bisphosphate, 0.4mmol L−1 NADP+,
0.7 UmL−1 G6PDH (EC 1.1.1.49), 2.8 U ml−1 phosphoglucose iso-
merase (PGI, EC 5.3.1.9); pH 7.5.
2.6. DNA quantiﬁcation
The DNA quantiﬁcation was performed using the Qubit™ dsDNA BR
Assay Kit and the Qubit® 2.0 Fluorometer (Thermo Fisher Scientiﬁc)
according to the manufacturer's instructions with aliquots from the
sonicated adMSC homogenates that were used for the enzyme activity
assays (for the preparation of these homogenates refer to section
“Enzyme activity assays”). The Qubit™ dsDNA BR Assay Kit is selective
for double-stranded DNA.
2.7. Quantiﬁcation of the expression of diﬀerent isoforms of LDH, NADP-
IDH and CK
The quantiﬁcation of LDH isoforms LDHA and LDHB; the NADP-IDH
isoforms IDH1, IDH2 and IDH3A and the CK isoforms CKB, CKM,
CKMT1B and CKMT2 was done using a real-time reverse transcriptase
polymerase chain reaction (real-time RT PCR). The cells were homo-
genized on QIAshredder columns (Qiagen). The RNA was isolated from
the lysate with the innuPREP RNA Mini Kit (Analytik Jena) following
the manufacturer's instructions. The RNA was then transcribed into
cDNA using the QuantiTect Reverse Transcription Kit (Qiagen). Speciﬁc
PCR templates were identiﬁed with the help of the reference sequence
collection “Gene”, accessible on the NCBI web page. After identifying
the diﬀerent existing isoforms of the enzymes concerned, a transcript
variant was chosen as a sequence template for the primers. The design
of the corresponding primer was done with the Primer-BLAST tool on
NCBI (see Table 1). Potential binding to residual genomic DNA was
tested for. The primers were purchased from Sigma-Aldrich. With the
7500 Real Time PCR system (Applied Biosystems), Real-time PCR of
transcribed samples was subsequently performed utilizing the Power
SYBR Green PCR Master Mix (Thermo Fisher Scientiﬁc). The collected
data were evaluated with the SDS 7500v 2.3 Software. Gene expression
levels were calculated with the ΔCT method with normalization to
human-speciﬁc 18S RNA and corrected for primer eﬃciency that was
determined with the Real-time PCR Miner algorithm [35].
2.8. Isolation and quantiﬁcation of adMSC mitochondria content
After 7 and 14 d in control and diﬀerentiation cultures in 6-well
plates, the cells were harvested. Their mitochondrial content was iso-
lated with the Mitochondria Isolation Kit (Miltenyi Biotech) and
quantiﬁed with the FluoroProﬁle® Protein Quantiﬁcation Kit. Isolation
as well as quantiﬁcation was done according to manufacturer's in-
structions. The mitochondrial isolate was disrupted by ultrasonication
for 30 s. Quantiﬁcation of the protein content in the mitochondrial
homogenate was done with a ﬂuorimetric assay based on epicocconone
[36]. The amount of mitochondria was then normalized to the cell
number that was determined via crystal violet staining. Enzyme activ-
ities of presumably cytoplasmic-only (GAPDH) and mitochondrial-only
(HOADH) enzymes were measured in the mitochondrial isolates as an
internal control for the quality of the mitochondria isolation. As had
been shown before, the isolation procedure of mitochondria with
paramagnetic beads renders a population of pure and functional mi-
tochondria [37]. In the same study no GAPDH could be found in mi-
tochondrial isolates harvested by the described method.
2.9. Statistical analysis
Numbers of donors are mentioned in the Figure and Table legends.
The data for one single donor was measured in a technical triplicate
(cell amount, ALP activity, lipid content) or duplicate (enzyme activity,
amount of DNA, expression of enzyme isoforms, mitochondrial pro-
tein). Calculations and statistical analyses were carried out with the
Excel 2013 and R software environment for statistical computing and
graphics [38] as well as GraphPad Prism version 7.02 for Windows
(GraphPad Software). The normality of the data distribution was tested
with the Shapiro-Wilk normality test. The homogeneity of variance of
enzyme activity data, cell culture analysis data, RNA expression data
und mitochondrial protein quantiﬁcation was analyzed with a U-test
according to Mann and Whitney (p < 0.05). All diagrams were created
with the GraphPad software. The data displayed are medians with the
interquartile range.
3. Results
3.1. Investigation of osteogenically and adipogenically diﬀerentiating
adMSC
Fluorescence microscopic images of the live/dead staining of all
culture conditions were taken after 21 d. These images displayed no
impairment of the cell vitality as the vital staining revealed regular cell
Table 1
qPCR primers used in this study.
Primer Sequence Target gene
18S_fw ATGGCCGTTCTTAGTTGGTG 18S ribosomal RNA
18S_re CGCTGAGCCAGTCAGTGTAG
LDHA_fw CTGTTCCACTTAAGGCCCCTC Homo sapiens lactate
dehydrogenase ALDHA_re GGAACCAAAAGGAATCGGGAATG
LDHB_fw CTCATTGCACCAGTTGCGG Homo sapiens lactate
dehydrogenase BLDHB_re TCAGCCAGAGACTTTCCCAG
IDH1_fw CTGCCCACGGGACTGTAAC Homo sapiens isocitrate
dehydrogenase 1
(NADP+), soluble (IDH1)
IDH1_re AGGCAAAAATGGAAGCAATGGG
IDH2_fw AGTGTACAACTTCCCCGCAG Homo sapiens isocitrate
dehydrogenase 2
(NADP+), mitochondrial
(IDH2)
IDH2_re ATAGTGCTTGTCAAAGATCTCCTGG
IDH3A_fw ACTGGTGGTGTTCAGACAGTAAC Homo sapiens isocitrate
dehydrogenase 3 (NAD+)
alpha
IDH3A_re CCACTGAATAGGTGCTTTGGC
CKM_fw CGACCTGGACCCTAACTACG Homo sapiens creatine
kinase, muscle typeCKM_re GTCAGGCTGTTGAGAGCTTCC
CKB_fw AGCTCATCGACGACCACTTC Homo sapiens creatine
kinase, brain typeCKB_re GTCATTGTGCCAGATACCGC
CKMT1B_fw CCTGTCCATCTAACCTGGGC Homo sapiens creatine
kinase, mitochondrial 1BCKMT1B_re TGGGAAGCGGCTATCTTTGC
CKMT2_fw CTCCAAGCGCAGACTACCC Homo sapiens creatine
kinase, mitochondrial 2
(sarcomeric)
CKMT2_re GGTGTCACCTTGTTGCGAAG
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growth and the staining indicative of dead cells rarely occurred
(Fig. 1A). Furthermore, the nuclear staining indicated an obvious dif-
ference in the amount of cells after 21 d as the nuclei number appeared
highest in osteogenic-stimulated adMSC. This observation was con-
ﬁrmed by the quantiﬁcation of the relative cell amount (Fig. 1B). In
non-stimulated adMSC cultures a 1.3-fold increase in cell number oc-
curred from day 7 to day 21. After 7 d of osteogenic stimulation the
amount of cells was 1.4-fold higher than in non-stimulated adMSC.
After 21 d in osteogenic culture the amount of cells had increased 3.7-
fold compared to non-stimulated adMSC. In contrast, the cell numbers
of adipogenically stimulated adMSC did not change signiﬁcantly over
the cultivation period of 21 d (Fig. 1B). The viability of the cells was
further veriﬁed by testing the metabolic activity at all time points of
measurement (Supplemental information S1). This assay showed no
impairment of vitality and is in agreement with the live/dead staining
and the cell number quantiﬁcation.
Osteogenic diﬀerentiation is characterized by the upregulation of
bone-speciﬁc molecules and enzymes like alkaline phosphatase (ALP)
as well as the mineralization of their extracellular matrix. Non-stimu-
lated adMSC did not show a speciﬁc osteogenic diﬀerentiation since
only few cells show a slight ALP-positivity (Fig. 2A); osteogenic sti-
mulation led to a distinct positivity for ALP-activity (Fig. 2B). Matrix
mineralization did not occur in unstimulated adMSC cultures (Fig. 2C),
whereas osteogenically stimulated adMSC showed a large number of
mineralization nodules (Fig. 2D). Adipogenic diﬀerentiation is char-
acterized by the formation of multilocular, lipid-ﬁlled vacuoles.
Whereas in non-stimulated adMSC no lipid accumulation was detect-
able (Fig. 2E), adipogenically stimulated adMSC showed numerous
lipid-ﬁlled vacuoles (Fig. 2F).
The quantiﬁcation of ALP activity revealed its 5-fold increase by
cultivation of adMSC with osteogenic stimulation for 21 d compared to
non-stimulated cultures (Fig. 3A). In contrast, the ALP activity of adi-
pogenically stimulated adMSC was 6-fold lower than the ALP activity in
osteogenically stimulated adMSC over the same period. The quantiﬁ-
cation of the lipid accumulation in adipogenically stimulated cultures
showed 5–6-fold increased values compared to non-stimulated and os-
teogenic cultures (Fig. 3B).
Fig. 1. Monitoring of adMSC vitality and relative cell amount in non-stimulated cultures (US), osteogenically stimulated cultures (OS) and adipogenically
stimulated cultures (AS). (A) live/dead staining after 21 d (green: cytoplasm of vital cells; red: nuclei of dead cells; blue: nuclei; scale bar: 100 µm); (B) relative cell
amount quantiﬁed after 7 and 21 d (n=4; * signiﬁcantly diﬀerent from US cultures at the respective time point; Mann-Whitney U-Test; p < 0.05).
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3.2. Enzyme activities of adMSC and diﬀerentiation-dependent changes
Important energy-metabolic pathways were examined by measuring
the maximum catalytic activities of several marker enzymes in non-
diﬀerentiating adMSC cultures and osteogenically or adipogenically
diﬀerentiating cultures (Fig. 4).
The regulatory enzyme of glycolysis is the PFK. In non-diﬀer-
entiating cultures, PFK activity increased with advanced cultivation
period (0.25 U/mg DNA and 0.5 U/mg DNA after 7 and 21 d) (Fig. 4A).
GAPDH and LDH (Fig. 4B and C) showed the highest activities of all
enzymes tested (e.g. 48 U/mg DNA and 7 U/mg DNA respectively after
7 d). The GAPDH and LDH activities were increased 1.6 and 2.3-fold
after 21 d (75 U/mg DNA and 16 U/mg DNA respectively). In osteo-
genically diﬀerentiating adMSC, the total increase of maximum PFK
activity was much higher compared to GAPDH and LDH (13-fold from
0.5 U/mg DNA after 7 d to 6.5 U/mg DNA after 21 d). Maximum
GAPDH activities of adMSC in osteogenic diﬀerentiation were only
slightly higher than in non-diﬀerentiating adMSC cultures (55 U/mg
DNA and 101 U/mg DNA after 7 and 21 d). LDH activity rose 4-fold in
osteogenic cultures (8 U/mg DNA and 35 U/mg DNA after 7 and 21 d)
compared to a 2.3-fold rise in non-diﬀerentiating cultures. Therefore, in
osteogenically diﬀerentiating cultures the ratio GAPDH/PFK was 15
after 21 d, which is 15-fold lower than in the non-diﬀerentiating cul-
tures. In adipogenically diﬀerentiating cultures the maximum activities
Fig. 2. Detection of diﬀerentiation in adMSC. (A) staining for ALP activity in non-stimulated adMSC and (B) in osteogenically stimulated adMSC after 21 d; (C)
staining of extracellular matrix mineralization in non-stimulated adMSC and (D) in osteogenically stimulated adMSC after 35 d; (E) lipid staining in non-stimulated
adMSC and (F) in adipogenically stimulated adMSC after 14 d (blue: nuclei, green: lipid), (scale bar: 100 µm).
Fig. 3. Quantiﬁcation of osteogenic
or adipogenic diﬀerentiation in non-
stimulated cultures (US), in osteogeni-
cally stimulated cultures (OS) and in
adipogenically stimulated cultures
(AS). (A) ALP activity after 21 d; (B)
quantiﬁcation of lipid accumulation
after 21 d (US, OS, AS, n= 4, * sig-
niﬁcantly diﬀerent from US; Mann-
Whitney U-Test, p < 0.05).
J. Meyer et al. Experimental Cell Research 370 (2018) 632–642
636
of PFK, GAPDH and LDH were lower than in the non-diﬀerentiating
cultures. PFK activity increased 2-fold with adipogenic stimulation
(0.2 U/mg DNA after 7 d and 0.4 U/mg DNA after 21 d), while GAPDH
activity did not change within the adipogenic cultivation period (20 U/
mg DNA after 7 and 21 d). LDH activities increased 2.7-fold by
adipogenic diﬀerentiation (3.7 U/mg DNA after 7 d and 10 U/mg DNA
after 21 d). The ratio GAPDH/PFK was 135 after 7 d and 61 after 21 d.
The marker enzyme of the pentose phosphate pathway (PPP),
G6PDH, displays relatively constant capacities in non-diﬀerentiating
cells with 3.1 U/mg DNA after 7 d and 3.5 U/mg DNA after 21 d
Fig. 4. Marker enzyme activities in non-diﬀerentiating (US), and osteogenically (OS) or adipogenically (AS) diﬀerentiating adMSC cultures after 7 and 21 d, (A)
PFK, (B) GAPDH, (C) LDH, (D) G6PDH, (E) NADP-IDH, (F) HOADH, (G) GSR, (H) CK; Activities were normalized to the overall DNA content of the cells (n= 8, *
signiﬁcantly diﬀerent from US cultures at the respective time point; Mann-Whitney U-Test, p < 0.05).
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(Fig. 4D). Osteogenic diﬀerentiation induced a 2.6-fold increase of
G6PDH activity (4.4 U/mg DNA after 7 d and 11.4 U/mg DNA after
21 d). Under adipogenic diﬀerentiation the G6PDH activity was below
the activities in non-diﬀerentiating cultures and did not signiﬁcantly
change within the adipogenic cultivation period (2.8 U/mg DNA after
7 d and 2.2 U/mg DNA after 21 d).
In order to assess the relevance of the citric acid cycle in adMSC in
vitro, the capacities of the marker enzymes NAD-IDH and NADP-IDH
were measured. Whereas NAD-IDH activity was not detectable at any
point of time in any cultivation condition, NADP-IDH activity was
evident (Fig. 4E). Non-diﬀerentiating cultures showed a low capacity of
the NADP-IDH that did not signiﬁcantly change during cultivation
(1.2 U/mg DNA after 7 d and 1.0 U/mg DNA after 21 d). In osteogeni-
cally and adipogenically diﬀerentiating adMSC cultures the NADP-IDH
activities were signiﬁcantly higher after the 21 d cultivation period
compared with the non-diﬀerentiating cultures (2.4 U/mg DNA and
2.1 U/mg DNA after 7 d respectively and 3.9 U/mg DNA and 2.5 U/mg
DNA after 21 d respectively).
The mitochondrial marker enzyme of fatty acid oxidation, HOADH,
showed low maximum activities under non-diﬀerentiating conditions
(0.5 U/mg DNA and 0.6 U/mg DNA after 7 and 21 d, Fig. 4F). The
HOADH activity in osteogenically diﬀerentiating cells was slightly
higher after 7 d (0.9 U/mg DNA) and increased 2.9-fold to 2.6 U/mg
DNA after 21 d. The overall highest HOADH activities were detected in
adipogenically diﬀerentiating adMSC. After 7 d of adipogenic stimula-
tion 1.4 U HOADH/mg DNA were detectable and HOADH activity also
increased 2.9-fold to 4 U/mg DNA after 21 d.
The GSR, which is part of the antioxidative defense system, showed
an increase over time under all cultivation conditions (Fig. 4G). Max-
imum activities in the non-diﬀerentiating cultures were comparatively
low (0.9 U/mg DNA and 1.7 U/mg DNA after 7 and 21 d). After 7 d
under osteogenic cultivation conditions, the capacity was already more
than twice as high and increased further after 21 d under osteogenic
stimulation (2.2 U/mg DNA and 6.3 U/mg DNA after 7 and 21 d). In
adipogenically diﬀerentiating cultures the GSR showed a capacity si-
milar to that in osteogenically diﬀerentiating cells after 7 d, but the
increase in the following 14 d of culture was less pronounced (2.3 U/mg
DNA and 3.5 U/mg DNA after 7 and 21 d).
CK activity, which is involved in buﬀering and recovery of ATP, was
present in adMSC. In adMSC cultures without speciﬁc stimulation the
maximum CK activities (Fig. 4H) were 2.1 U/mg DNA after 7 d and no
signiﬁcant changes appeared with advanced cultivation time (2.2 U/mg
DNA after 21 d). In osteogenically diﬀerentiating cultures the CK ca-
pacities were higher than in non-diﬀerentiating cultures (4.1 U/mg
DNA and 3.9 U/mg DNA after 7 and 21 d). The highest CK activities
were found in adipogenically diﬀerentiating cultures (5.3 U/mg DNA
after 7 d and 5.9 U/mg DNA after 21 d of culture). Activities of the
marker enzyme of gluconeogenesis, FBPase, could not be detected.
3.3. Expression level of isoforms of LDH, IDH and CK
The necessity for the adaption of the gene expression for the dif-
ferent isoforms of LDH, IDH and CK was elucidated by determining
their gene expression levels after 7 and 14 d of cultivation.
Among LDH isoforms, LDHB is the prevailingly expressed isoform in
adMSC (Fig. 5A). The expression level is 100–1000 times higher than
that of the LDHA isoform. The osteogenic and adipogenic diﬀerentia-
tion induced no signiﬁcant diﬀerences in the expression of LDHB.
The gene expression status of the IDH isoforms is more complex
(Fig. 5B). Whereas in non-diﬀerentiating and osteogenic cultures the
expression of IDH2 (mitochondrial NADP-dependent isoform) is pre-
dominant, the IDH1 (cytosolic NADP-dependent isoform) is strongly
expressed in adipogenically diﬀerentiated cultures. IDH1 expression
was 8-fold higher in adipogenic diﬀerentiation than in the non-diﬀer-
entiating cultures after 14 d. Furthermore, the expression of IDH2 also
increased about 3-fold in adipogenic diﬀerentiation at both time points.
Osteogenic diﬀerentiation also induced an increase of IDH2 (about 2-
fold at 14 d). Interestingly, the gene expression of the mitochondrial
NAD-dependent isoform IDH3A, which lacks activity on the protein
level, was detectable under all culture conditions. It was expressed at a
low level in non-diﬀerentiating cultures. The expression increased
about 3-fold in osteogenic diﬀerentiation and up to 6-fold in adipogenic
diﬀerentiation.
The predominantly expressed CK isoform in adMSC is the CKB
(cytosolic brain type isoform, Fig. 5C). The CKB is expressed 50-fold
and 600-fold higher than the mitochondrial isoforms CKMT2 and
CKMT1B at the start of the experiment, respectively (see Supplementary
material Fig. S2). In non-diﬀerentiating adMSC cultures and osteo-
genically stimulated adMSC cultures the CKB expression decreased with
cultivation time. Notably, the adipogenic diﬀerentiation induced a
signiﬁcantly increased expression of the mitochondrial isoforms
CKMT1B and CKMT2. CKMT1B is 270- and 530-fold higher compared
with non-diﬀerentiating cultures after 7 and 14 d, CKMT2 is 12 and 34-
fold higher after 7 and 14 d, respectively. Expression of the muscle type
CK gene CKM could not be detected.
3.4. Evaluation of the mitochondrial mass of non-diﬀerentiating adMSC
and adMSC under mesenchymal diﬀerentiation
To assess whether the changes in protein and RNA expression levels
in mitochondrial enzymes were due to a speciﬁc increase of catalytic
activity and its gene expression level or to an overall rise in mi-
tochondrial mass, the amount of mitochondrial protein was quantiﬁed
(Fig. 6).
Fig. 5. Gene expression levels in non-diﬀerentiating (US) and osteogenically
(OS) or adipogenically (AS) diﬀerentiating adMSC after 7 and 14 d (A) LDH
isoforms LDHA and LDHB, (B) IDH isoforms IDH1, IDH2 and IDH3A, (C) CK
isoforms CKB, CKMT1B and CKMT2, normalized to 18s RNA-expression (n= 3,
all culture conditions were compared within one time point, * indicate sig-
niﬁcant diﬀerences, level of signiﬁcance: p≤ 0.05).
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After 14 days of osteogenic diﬀerentiation, the mitochondrial mass
per cell was 2-fold lower compared with non-diﬀerentiating cultures. At
the same time the adMSC in adipogenically diﬀerentiating cultures had
a signiﬁcant, 1.4-fold higher amount of mitochondrial mass per cell
compared to non-diﬀerentiating cultures. The eﬃciency of mitochon-
drial isolation was evaluated by the detection of the presence of the
exclusively mitochondrial enzyme HOADH (see Supplementary mate-
rial Table S1).
4. Discussion
In this study we analyzed the activity and gene expression of marker
enzymes of energy metabolism in adMSC in non-diﬀerentiating adMSC
in vitro and how it is inﬂuenced by osteogenic and adipogenic diﬀer-
entiation.
4.1. Proliferation and diﬀerentiation of adMSC
Moderate proliferative activity was shown to occur in the non-sti-
mulated cultures, and high proliferative activity was induced in os-
teogenic diﬀerentiation over the 21 days of cultivation. On the other
hand, the constant cell amount in the adipogenically diﬀerentiating
adMSC over the experimentation period of 21 d indicates a lack of
proliferative activity, as was previously shown [29].
By the detection of the osteogenic diﬀerentiation markers ALP ac-
tivity and extracellular matrix mineralization [39], we could show that
osteogenic stimulation of adMSC led to osteogenic diﬀerentiation. It
was previously shown that the osteogenic diﬀerentiation of adMSC is
accompanied by increased expression of the osteoblastogenic marker
ZBTB16 (zinc ﬁnger and BTB domain containing 16) [40] and increased
expression of osteocalcin and osteopontin [41,42]. The adipogenic
diﬀerentiation of adMSC was also shown, as a pronounced lipid vacuole
formation was detected in adipogenically stimulated cultures. The ap-
plied diﬀerentiation protocol is shown to induce adipogenic diﬀer-
entiation accompanied by the expression of leptin, glucose transporter
GLUT4, PPARγ2 (peroxisome-proliferating activated receptor γ), LPL
(lipoprotein lipase), and aP2 (adipocyte protein 2) [4,5,41,43].
We investigated the capacity of diﬀerent energy metabolic path-
ways on the basis of these three in vitro approaches: 1) non-diﬀer-
entiating, slightly proliferating adMSC, 2) osteogenically diﬀer-
entiating, highly proliferative adMSC, and 3) adipogenically
diﬀerentiating, non-proliferating adMSC.
4.2. Metabolism
The enzyme activities in vivo can diverge from maximum activities
measured in vitro under optimal conditions. Therefore the maximum
activities presented in this study represent a capacity of metabolic
turnover and not the turnover in vivo in a speciﬁc metabolic state.
However, previous studies have shown a good correlation of the ca-
pacities of energy pathway marker enzymes with their contribution to
energy metabolism [44].
The glycolytic marker enzymes GAPDH and LDH showed the
highest activities in adMSC at any time, suggesting a high capacity of
carbohydrate catabolism. In non-diﬀerentiating adMSC, which showed
moderate proliferation, GAPDH and LDH activities increased with cul-
tivation time. The activity of the regulatory enzyme of glycolysis, PFK,
is a magnitude lower compared to GAPDH as well as LDH. This has been
shown before in endothelial cells [34] and might reﬂect the fact that
GAPDH and LDH catalyze the reactions rather near the thermodynamic
equilibrium of the reaction in vivo, in contrast to the regulatory enzyme
PFK [20].
We could demonstrate that the osteogenic diﬀerentiation of adMSC
is accompanied by a high cell division rate and characterized by an
increase of all enzyme activities tested. This indicates an increased
capacity for all energy metabolic pathways. Thus both the carbohydrate
metabolism and the mitochondrial metabolism appeared enhanced in
osteogenic diﬀerentiation. For both cell division and stem cell diﬀer-
entiation, a de novo synthesis of macromolecules is necessary [45,46].
In proliferating cell cultures, a preference for carbohydrate metabolism
to lactate (glycolysis) under aerobic conditions is demonstrated
[18,34]. This phenomenon is deﬁned as the Warburg eﬀect [47]. This
less eﬃcient energy pathway might be a way to increase the carbon ﬂux
through biosynthetic pathways [18]. However, the presence of the
Warburg eﬀect cannot be explicitly concluded by our data. Previous
studies on the metabolism of MSC during diﬀerentiation have yielded
controversial results. Pattappa et al. demonstrated a suppression of
glycolysis in osteogenically diﬀerentiating bmMSC, suggesting a pro-
portionate increase in oxidative phosphorylation [23]. Chen et al. re-
ported a transition from glycolysis to oxidative phosphorylation in
bmMSC upon osteogenic induction with a distinct decrease in glycolysis
[48]. Shum et al. reported an induction of oxidative phosphorylation
upon osteogenic diﬀerentiation of bmMSC, whereby the level of gly-
colysis was unchanged compared to undiﬀerentiated bmMSC [49].
These results partially diverge from our ﬁndings which indicate the
simultaneous increase of carbohydrate metabolism, oxidative phos-
phorylation and β-oxidation upon osteogenic diﬀerentiation. These
controversial results may result from diﬀerent analyzed targets and
analytical methods as well as the fact that, in the other studies, mostly
bmMSC were examined [50]. Furthermore, the large diﬀerences in cell
culture conditions, e.g. as displayed in the diﬀerences of medium
composition with partially supraphysiological levels of glucose, gluta-
mine and pyruvate, might inﬂuence the cell metabolism [51]. Thus,
further examinations will be necessary.
The presence of LDH activity and its increase within the cultivation
period in all cultures indicates the capacity of adMSC for anaerobic
energy production and/or the use of lactate as an aerobic substrate. The
use of lactate for gluconeogenesis is improbable because no activity of
the enzyme FBPase was detectable in adMSC. The striking dominance of
the expression of the B subunit of LDH (heart type) indicates a pre-
ference for the conversion of lactate to the 3-carbon compound pyr-
uvate [52]. On the other hand, a high consumption rate of glucose
followed by a high discharge rate of lactate under standard cultivation
conditions was shown for proliferating bmMSC and adMSC [22,53,54].
Adipogenically diﬀerentiated adMSC do not proliferate. Thus, the
constant levels of GAPDH capacity during adipogenic diﬀerentiation
simultaneous to the minor increase of PFK capacity may be caused by
the ongoing lipid synthesis. During lipid synthesis, dihydroxyacetone
phosphate is diverted from glycolysis and used for the anabolic
pathway of lipid synthesis prior to the action of GAPDH in glycolysis
[55]. The 2.7-fold increase of LDH within 2 weeks could imply the
presence of the Warburg eﬀect in adipogenically diﬀerentiating cells.
But the Warburg eﬀect has so far been detected in highly proliferating
cells [55]. With the lack of proliferation, adipogenically diﬀerentiating
Fig. 6. Relative mitochondrial mass displayed as amount of mitochondrial
protein normalized to cell number after 7 and 14 d in non-diﬀerentiating
adMSC (US) and in osteogenic (OS) or adipogenic diﬀerentiation (AS). (n= 5, *
indicate signiﬁcant diﬀerences, level of signiﬁcance: p≤ 0.05).
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adMSC are missing this essential characteristic. Furthermore, as in-
ferred from studies with white adipose tissue of rats, it has been sug-
gested that in white adipocytes the main role of LDH may be the con-
version of excess available glucose into the 3-carbon compound
pyruvate in order to limit tissue self-utilization as a substrate [56]. This
is supported by our data regarding the dominance of the expression of
the LDH B subunit, which implies a preference for a lactate to pyruvate
conversion.
G6PDH controls the ﬂux of carbon through the PPP and competes
with glycolysis for sugar metabolism. We could show a high G6PDH
capacity in non-diﬀerentiating and diﬀerentiating adMSC. High G6PDH
activities indicate the importance of the PPP for anabolism [34,57].
Strikingly, G6PDH activities were even higher than the control enzyme
of glycolysis PFK. Thus the ratio of G6PDH to PFK is larger than 1. For
example, in proliferating endothelial cells or carcinoma cells the ratios
are lower (0.68 and 0.4–0.2, respectively). In frog skeletal muscle the
values are actually below 0.001 [34]. Therefore a high ratio of G6PDH/
PFK might be typical for proliferating and/or diﬀerentiating cells, as
these are characterized by a relatively high anabolic metabolism.
The PPP delivers not only pentoses for the biosynthesis of macro-
molecules (e.g. nucleic acids) [12] but also reduction equivalents in the
form of NAPDH+H+ which are essential for biosynthesis (particularly
lipogenesis) [58]. The regulation of the PPP capacity is strongly de-
pendent on the regulation of lipid synthesis [59]. The high expression
of the cytoplasm NADP-dependent IDH encoded by IDH1 might be due
to a high consumption of NADPH in the cytoplasm for lipid synthesis.
Correspondingly, the expression level of IDH1 prevails in adipogeni-
cally induced adMSC, where lipids are accumulated in vacuoles.
The enzyme activity measurements and mitochondria quantiﬁca-
tions show that the HOADH activity and thus the capacity for ß-oxi-
dation increases distinctly in adipogenic as well as in osteogenic dif-
ferentiation in vitro. Consistent with our results, a constant
mitochondrial mass during osteogenic diﬀerentiation [48,49] and a
distinct increase in mitochondrial mass during adipogenic diﬀerentia-
tion [25,60] have been found by others before. Ultimately, it is not
known if the fatty acid synthesis and ß-oxidation occur simultaneously
within one cell. Studies with white adipose tissue have shown that in
the anabolic state, lipolysis is inhibited [12,61]. Whether this is a
common regulatory mechanism remains to be elucidated since e.g. the
conversion of white to brown adipocytes entails an upregulation of both
fatty acid anabolic and catabolic pathways [62].
A mitochondrial NAD-dependent IDH activity could not be detected,
thus a part of NADP-IDH might be located in the mitochondria because
IDH is required for the citric acid cycle [19]. Correspondingly, the ex-
pression of IDH2 in adMSC and its increase during osteogenesis and
adipogenesis support the existence of mitochondrial NADP-IDH. At a
lower but signiﬁcant level, IDH3A, the catalytic NAD-IDH subunit, was
also expressed in all adMSC. One explanation of this apparent dis-
crepancy between the activity and the expression level could be that the
expression of the catalytic α-subunit of IDH3A did not represent the
total expression of NAD-IDH. In contrast to the homologous dimer
NADP-IDH, the NAD-IDH contains two diﬀerent regulatory subunits
which allow allosteric regulation of the activity, particularly by cell
energy charge (e.g. ADP/ATP) [63]. Translation to an active NAD-IDH
can still be suppressed through alternatively spliced gene products of
the regulatory subunits. NAD-IDH is particularly present in tissues with
a high respiratory ATP turnover, like aerobic muscles, while in pro-
liferating cells the NADP-IDH prevails [34]. It is being discussed that in
proliferating and biosynthetically active cells most of the carbon that
enters the TCA cycle is directed towards biosynthetic pathways rather
than ATP production [45]. Thus e.g. for fatty acid synthesis, citrate
could be removed from the TCA cycle prior to the action of NAD-de-
pendent IDH. One reason the NADP-dependent IDH might be favoured
in biosynthetically active cells is that, in contrast to the irreversible
reaction of NAD-dependent conversion of isocitrate to oxoglutarate, the
NADP-dependent reaction is reversible. This allows an anaplerotic
pathway, forming isocitrate by glutaminolysis (reviewed in [64]). Using
this pathway, glutamine can compensate for the lack of glucose not only
for ATP-production but also for the supply of anabolic precursors [65].
The low GSR activities measured in non-diﬀerentiating, pro-
liferating cells over the entire time of cultivation indicate a low activity
of oxidative phosphorylation in the mitochondria of these cells. Low
oxidative phosphorylation activity has also been shown for pro-
liferating thymocytes [66]. The signiﬁcant increase of GSR activity in
osteogenically diﬀerentiating cells and the slight increase during adi-
pogenic diﬀerentiation might be caused by the demand for regeneration
of the detoxiﬁcation system for reactive oxygen species during en-
hanced anabolism [67]. Furthermore, it has been reported that, upon
adipogenic diﬀerentiation of bmMSC and adipose progenitors, the
oxygen consumption increased [25,68]. Simultaneously, antioxidative
defense enzymes were upregulated [25]. These data and our data
suggest that the correlation of mitochondrial oxidative activity, en-
hanced anabolism and regulation of antioxidative defense need to be
further elucidated.
High CK activity is found in the cytoplasm of cells with temporarily
high or ﬂuctuating energy demands (e.g. fast twitch muscle), where it
regenerates ATP for seconds [69]. CK stimulates glycogenolysis by a
multiple increase of the cytoplasmic, inorganic phosphate concentra-
tion [70]. This function is oxygen-independent, but the ﬁnding of a
mitochondrial isozyme led to the idea of a functional coupling of CK
with oxidative phosphorylation [69,71]. CK activities were found in all
adMSC cultures but the gene expression data suggest that mitochondrial
CKs were expressed particularly in adipogenically stimulated cells. This
suggests that adipogenic stimulation shifted the energy metabolism
towards a more oxidative metabolism than osteogenic stimulation did.
The expression levels of CKB, CKMT1B and CKMT2 increasing with the
progressing adipogenic diﬀerentiation imply an increasing role of a
functional phosphocreatine-CK shuttle [69]. This shuttle has been
found in human skin that was characterized as having high metabolic
rates and energy turnover. In these cells the shuttle was mainly made up
of the brain type CK and the ubiquitous mitochondrial CK [72]. Thus,
although adipogenically induced cells do not proliferate, they show a
metabolic phenotype that is characteristic for rapid ATP turnover.
In conclusion, the present data indicate that osteogenically diﬀer-
entiating adMSC in vitro showed a strongly proliferative phenotype that
entails an increase in the capacity of all energy metabolic pathways
tested (Fig. 7A). In contrast, the adipogenic diﬀerentiation of adMSC,
associated with a lack of proliferation, is accompanied by a decreasing
capacity for PPP and carbohydrate metabolism. At the same time, mi-
tochondrial enzyme activities increase indicating a growing capacity for
oxidative phosphorylation and β-oxidation (Fig. 7B). Thus, adipogeni-
cally diﬀerentiating adMSC in vitro indicate a shift of their energy
metabolic capacity towards lipid metabolism.
While correlations between the proliferative state during osteogenic
and adipogenic diﬀerentiation and metabolic rearrangements within
the cells could be presented by this study, further investigations will be
necessary to verify causal connections in proliferating and diﬀer-
entiating adMSC in vitro and in vivo.
Acknowledgments
The authors thank Dr. med. habil. Jürgen Weber (Ästhetikklinik
Rostock, Germany), Dr. med. Klaus Ueberreiter (Park-Klinik
Birkenwerder, Germany) and their patients for kindly providing lipo-
suction tissue. Special thanks are also given to Steﬃ Adam for the
technical assistance. This work was ﬁnancially supported by the
European Union (EFRE) and the Federal State of Mecklenburg-
Vorpommern (SYNTERO, V-630-S-083-2010/245 and V-630-F-083-
2010/248 and Jet Stem Cell Collector, V-630-S-120-2011/122 and V-
630-F-120-2011/123), and the “ASCaﬀolds” project funded by the
German Federal Ministry of Education and Research (ERA NET/
EuroTransBio-7, Grant no. 031A244C).
J. Meyer et al. Experimental Cell Research 370 (2018) 632–642
640
Disclosure statement
The authors declare that they have no conﬂicts of interest with the
contents of this article.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the
online version at doi:10.1016/j.yexcr.2018.07.028.
References
[1] R.H. Lee, B. Kim, I. Choi, H. Kim, H.S. Choi, K. Suh, Y.C. Bae, J.S. Jung,
Characterization and expression analysis of mesenchymal stem cells from human
bone marrow and adipose tissue, Cell. Physiol. Biochem. 14 (2004) 311–324.
[2] D. Peroni, I. Scambi, A. Pasini, V. Lisi, F. Bifari, M. Krampera, G. Rigotti,
A. Sbarbati, M. Galie, Stem molecular signature of adipose-derived stromal cells,
Exp. Cell Res. 314 (2008) 603–615.
[3] D. Spitkovsky, J. Hescheler, Adult mesenchymal stromal stem cells for therapeutic
applications, Minim. Invasive Ther. Allied Technol. 17 (2008) 79–90.
[4] P.A. Zuk, M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, H. Mizuno, Z.C. Alfonso,
J.K. Fraser, P. Benhaim, M.H. Hedrick, Human adipose tissue is a source of multi-
potent stem cells, Mol. Biol. Cell 13 (2002) 4279–4295.
[5] P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J. Katz, P. Benhaim,
H.P. Lorenz, M.H. Hedrick, Multilineage cells from human adipose tissue: im-
plications for cell-based therapies, Tissue Eng. 7 (2001) 211–228.
[6] M. Valtieri, A. Sorrentino, The mesenchymal stromal cell contribution to home-
ostasis, J. Cell. Physiol. 217 (2008) 296–300.
[7] D.A. De Ugarte, K. Morizono, A. Elbarbary, Z. Alfonso, P.A. Zuk, M. Zhu,
J.L. Dragoo, P. Ashjian, B. Thomas, P. Benhaim, I. Chen, J. Fraser, M.H. Hedrick,
Comparison of multi-lineage cells from human adipose tissue and bone marrow,
Cells Tissues Organs 174 (2003) 101–109.
[8] A.W. James, J.N. Zara, X.L. Zhang, A. Askarinam, R. Goyal, M. Chiang, W. Yuan,
L. Chang, M. Corselli, J. Shen, S. Pang, D. Stoker, B. Wu, K. Ting, B. Peault, C. Soo,
Perivascular stem cells: a prospectively puriﬁed mesenchymal stem cell population
for bone tissue engineering, Stem Cell Transl. Med. 1 (2012) 510–519.
[9] Z.M. MacIsaac, H. Shang, H. Agrawal, N. Yang, A. Parker, A.J. Katz, Long-term in-
vivo tumorigenic assessment of human culture-expanded adipose stromal/stem
cells, Exp. Cell Res. 318 (2012) 416–423.
[10] B. Fang, Y. Song, R.C. Zhao, Q. Han, Q. Lin, Using human adipose tissue-derived
mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease
resembling acute hepatitis, Transplant. Proc. 39 (2007) 1710–1713.
[11] K.S. Koh, T.S. Oh, H. Kim, I.W. Chung, K.W. Lee, H.B. Lee, E.J. Park, J.S. Jung,
I.S. Shin, J.C. Ra, J.W. Choi, Clinical application of human adipose tissue-derived
mesenchymal stem cells in progressive hemifacial atrophy (Parry-Romberg disease)
with microfat grafting techniques using 3-dimensional computed tomography and
3-dimensional camera, Ann. Plast. Surg. 69 (2012) 331–337.
[12] N.S. Chandel, Navigating Metabolism, Cold Spring Harbor Laboratory Press, New
York, 2015.
[13] A. Rupprecht, D. Sittner, A. Smorodchenko, K.E. Hilse, J. Goyn, R. Moldzio,
A.E. Seiler, A.U. Brauer, E.E. Pohl, Uncoupling protein 2 and 4 expression pattern
during stem cell diﬀerentiation provides new insight into their putative function,
PLoS One 9 (2014) e88474.
[14] P.S. Ward, C.B. Thompson, Metabolic reprogramming: a cancer hallmark even
warburg did not anticipate, Cancer Cell 21 (2012) 297–308.
[15] J.D. Ochocki, M.C. Simon, Nutrient-sensing pathways and metabolic regulation in
stem cells, J. Cell Biol. 203 (2013) 23–33.
[16] N. Shyh-Chang, G.Q. Daley, Metabolic switches linked to pluripotency and em-
bryonic stem cell diﬀerentiation, Cell Metab. 21 (2015) 349–350.
[17] T. Lonergan, B. Bavister, C. Brenner, Mitochondria in stem cells, Mitochondrion 7
(2007) 289–296.
[18] M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Understanding the Warburg
eﬀect: the metabolic requirements of cell proliferation, Science 324 (2009)
1029–1033.
[19] D.L. Nelson, M.M. Cox, Lehninger Principles of Biochemistry, W. H. Freeman, New
York, 2013.
[20] E.A. Newsholme, C. Start, Regulation des Stoﬀwechsels. Homöostase im mens-
chlichen und tierischen Organismus, Verlag Chemie, Weinheim, 1984.
[21] D. Pette, Zellphysiologie des Stoﬀwechsels, Konstanzer Universitätsverlag,
Konstanz, 1970.
[22] D. Schop, F.W. Janssen, L.D. van Rijn, H. Fernandes, R.M. Bloem, J.D. de Bruijn,
R. van Dijkhuizen-Radersma, Growth, metabolism, and growth inhibitors of me-
senchymal stem cells, Tissue Eng. Part A 15 (2009) 1877–1886.
[23] G. Pattappa, H.K. Heywood, J.D. de Bruijn, D.A. Lee, The metabolism of human
mesenchymal stem cells during proliferation and diﬀerentiation, J. Cell. Physiol.
226 (2011) 2562–2570.
[24] Q. Li, Z. Gao, Y. Chen, M.X. Guan, The role of mitochondria in osteogenic, adipo-
genic and chondrogenic diﬀerentiation of mesenchymal stem cells, Protein Cell 8
(2017) 439–445.
[25] Y. Zhang, G. Marsboom, P.T. Toth, J. Rehman, Mitochondrial respiration regulates
adipogenic diﬀerentiation of human mesenchymal stem cells, PLoS One 8 (2013)
e77077.
[26] K. Peters, A. Salamon, S. Van Vlierberghe, J. Rychly, M. Kreutzer, H.G. Neumann,
E. Schacht, P. Dubruel, A new approach for adipose tissue regeneration based on
human mesenchymal stem cells in contact to hydrogels – an in vitro study, Adv.
Eng. Mater. 11 (2009) B155–B161.
[27] K. Noeske, The binding of crystal violet on deoxyribonucleic acid. Cytophotometric
studies on normal and tumor cell nuclei, Histochemie 7 (1966) 273–287.
[28] R.J. Gillies, N. Didier, M. Denton, Determination of cell number in monolayer
cultures, Anal. Biochem. 159 (1986) 109–113.
[29] A. Salamon, A. Jonitz-Heincke, S. Adam, J. Rychly, B. Muller-Hilke, R. Bader,
K. Lochner, K. Peters, Articular cartilage-derived cells hold a strong osteogenic
diﬀerentiation potential in comparison to mesenchymal stem cells in vitro, Exp. Cell
Res. 319 (2013) 2856–2865.
[30] J. Meyer, A. Salamon, N. Herzmann, S. Adam, H.D. Kleine, I. Matthiesen,
K. Ueberreiter, K. Peters, Isolation and diﬀerentiation potential of human me-
senchymal stem cells from adipose tissue harvested by water jet-assisted liposuc-
tion, Aesthet. Surg. J. 35 (2015) 1030–1039.
[31] J. Montalibet, K.I. Skorey, B.P. Kennedy, Protein tyrosine phosphatase: enzymatic
assays, Methods 35 (2005) 2–8.
[32] L.L. Listenberger, D.A. Brown, Fluorescent detection of lipid droplets and associated
proteins, Curr. Protoc. Cell Biol. (2007) (Chapter 24, Unit 24.22).
[33] H.U. Bergmeyer, J. Bergmeyer, M. Grassl, Methods of Enzymatic Analysis, Verlag
Chemie, Weinheim, 1983.
[34] K. Peters, G. Kamp, A. Berz, R.E. Unger, S. Barth, A. Salamon, J. Rychly,
C.J. Kirkpatrick, Changes in human endothelial cell energy metabolic capacities
during in vitro cultivation. The role of "aerobic glycolysis" and proliferation, Cell.
Physiol. Biochem. 24 (2009) 483–492.
[35] S. Zhao, R.D. Fernald, Comprehensive algorithm for quantitative real-time poly-
merase chain reaction, J. Comput. Biol. 12 (2005) 1047–1064.
[36] P.J. Bell, P. Karuso, Epicocconone, a novel ﬂuorescent compound from the fungus
epicoccumnigrum, J. Am. Chem. Soc. 125 (2003) 9304–9305.
[37] H.T. Hornig-Do, G. Gunther, M. Bust, P. Lehnartz, A. Bosio, R.J. Wiesner, Isolation
of functional pure mitochondria by superparamagnetic microbeads, Anal. Biochem.
389 (2009) 1–5.
[38] R.D.C. Team, R: A Language and Environment for Statistical Computing, R Found.
Stat. Comput., Vienna, Austria, 2011.
[39] J.E. Aubin, Bone stem cells, J. Cell. Biochem. Suppl. 30–31 (1998) 73–82.
[40] A. Salamon, S. Adam, J. Rychly, K. Peters, Long-term tumor necrosis factor treat-
ment induces NFkappaB activation and proliferation, but not osteoblastic diﬀer-
entiation of adipose tissue-derived mesenchymal stem cells in vitro, Int. J. Biochem.
Cell Biol. 54 (2014) 149–162.
[41] G. Astori, F. Vignati, S. Bardelli, M. Tubio, M. Gola, V. Albertini, F. Bambi, G. Scali,
D. Castelli, V. Rasini, G. Soldati, T. Moccetti, "In vitro" and multicolor phenotypic
characterization of cell subpopulations identiﬁed in fresh human adipose tissue
stromal vascular fraction and in the derived mesenchymal stem cells, J. Transl.
Med. 5 (2007) 55.
[42] J.A. Lee, B.M. Parrett, J.A. Conejero, J. Laser, J. Chen, A.J. Kogon, D. Nanda,
R.T. Grant, A.S. Breitbart, Biological alchemy: engineering bone and fat from fat-
derived stem cells, Ann. Plast. Surg. 50 (2003) 610–617.
Fig. 7. Schematic depiction of the indicated metabolic rearrangements in adMSC during (A) osteogenic and (B) adipogenic diﬀerentiation in relation to non-
diﬀerentiating adMSC (increased↑, decreased↓; Ox Phos: oxidative phosphorylation, PCreatine: phosphocreatine).
J. Meyer et al. Experimental Cell Research 370 (2018) 632–642
641
[43] T.M. Liu, M. Martina, D.W. Hutmacher, J.H. Hui, E.H. Lee, B. Lim, Identiﬁcation of
common pathways mediating diﬀerentiation of bone marrow- and adipose tissue-
derived human mesenchymal stem cells into three mesenchymal lineages, Stem
Cells 25 (2007) 750–760.
[44] E.A. Newsholme, A.R. Leech, Biochemistry for the Medical Sciences, J. Wiley and
Sons, Chichester and New York, 1983.
[45] R.J. DeBerardinis, J.J. Lum, G. Hatzivassiliou, C.B. Thompson, The biology of
cancer: metabolic reprogramming fuels cell growth and proliferation, Cell Metab. 7
(2008) 11–20.
[46] G. Musumeci, A. Mobasheri, F.M. Trovato, M.A. Szychlinska, A.C. Graziano, D. Lo
Furno, R. Avola, S. Mangano, R. Giuﬀrida, V. Cardile, Biosynthesis of collagen I, II,
RUNX2 and lubricin at diﬀerent time points of chondrogenic diﬀerentiation in a 3D
in vitro model of human mesenchymal stem cells derived from adipose tissue, Acta
Histochem. 116 (2014) 1407–1417.
[47] O. Warburg, On the origin of cancer cells, Science 123 (1956) 309–314.
[48] C.T. Chen, Y.R. Shih, T.K. Kuo, O.K. Lee, Y.H. Wei, Coordinated changes of mi-
tochondrial biogenesis and antioxidant enzymes during osteogenic diﬀerentiation
of human mesenchymal stem cells, Stem Cells 26 (2008) 960–968.
[49] L.C. Shum, N.S. White, B.N. Mills, K.L. Bentley, R.A. Eliseev, Energy metabolism in
mesenchymal stem cells during osteogenic diﬀerentiation, Stem Cells Dev. 25
(2016) 114–122.
[50] N. Quarto, D.C. Wan, M.D. Kwan, N.J. Panetta, S. Li, M.T. Longaker, Origin matters:
diﬀerences in embryonic tissue origin and Wnt signaling determine the osteogenic
potential and healing capacity of frontal and parietal calvarial bones, J. Bone Miner.
Res. 25 (2010) 1680–1694.
[51] M.D. Brand, D.G. Nicholls, Assessing mitochondrial dysfunction in cells, Biochem. J.
435 (2011) 297–312.
[52] D.M. Dawson, N.O. Kaplan, T.L. Goodfriend, Lactic dehydrogenases – functions of
two types – rates of synthesis of two major forms can be correlated with metabolic
diﬀerentiation, Science 143 (1964) 929–933.
[53] K.E. Follmar, F.C. Decroos, H.L. Prichard, H.T. Wang, D. Erdmann, K.C. Olbrich,
Eﬀects of glutamine, glucose, and oxygen concentration on the metabolism and
proliferation of rabbit adipose-derived stem cells, Tissue Eng. 12 (2006)
3525–3533.
[54] B.T. Mischen, K.E. Follmar, K.E. Moyer, B. Buehrer, K.C. Olbrich, L.S. Levin,
B. Klitzman, D. Erdmann, Metabolic and functional characterization of human
adipose-derived stem cells in tissue engineering, Plast. Reconstr. Surg. 122 (2008)
725–738.
[55] S.Y. Lunt, M.G. Vander Heiden, Aerobic glycolysis: meeting the metabolic re-
quirements of cell proliferation, Annu. Rev. Cell Dev. Biol. 27 (2011) 441–464.
[56] S. Arriaran, S. Agnelli, D. Sabater, X. Remesar, J.A. Fernandez-Lopez, M. Alemany,
Evidences of basal lactate production in the main white adipose tissue sites of rats.
Eﬀects of sex and a cafeteria diet, PLoS One 10 (2015) e0119572.
[57] W.N. Tian, L.D. Braunstein, J. Pang, K.M. Stuhlmeier, Q.C. Xi, X. Tian, R.C. Stanton,
Importance of glucose-6-phosphate dehydrogenase activity for cell growth, J. Biol.
Chem. 273 (1998) 10609–10617.
[58] B.L. Horecker, The biochemistry of sugars, Int. Z. fur Vitam.- und Ernahr. Beih. 15
(1976) 1–21.
[59] H. Kather, M. Rivera, K. Brand, Interrelationship and control of glucose metabolism
and lipogenesis in isolated fat-cells. Control of pentose phosphate-cycle activity by
cellular requirement for reduced nicotinamide adenine dinucleotide phosphate,
Biochem. J. 128 (1972) 1097–1102.
[60] L. Wilson-Fritch, A. Burkart, G. Bell, K. Mendelson, J. Leszyk, S. Nicoloro, M. Czech,
S. Corvera, Mitochondrial biogenesis and remodeling during adipogenesis and in
response to the insulin sensitizer rosiglitazone, Mol. Cell. Biol. 23 (2003)
1085–1094.
[61] J.M. Rutkowski, J.H. Stern, P.E. Scherer, The cell biology of fat expansion, J. Cell
Biol. 208 (2015) 501–512.
[62] V. Barquissau, D. Beuzelin, D.F. Pisani, G.E. Beranger, A. Mairal, A. Montagner,
B. Roussel, G. Tavernier, M.A. Marques, C. Moro, H. Guillou, E.Z. Amri, D. Langin,
White-to-brite conversion in human adipocytes promotes metabolic reprogramming
towards fatty acid anabolic and catabolic pathways, Mol. Metab. 5 (2016) 352–365.
[63] D.T. Hartong, M. Dange, T.L. McGee, E.L. Berson, T.P. Dryja, R.F. Colman, Insights
from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs
cycle, Nat. Genet. 40 (2008) 1230–1234.
[64] K. Smolkova, P. Jezek, The role of mitochondrial NADPH-dependent isocitrate
dehydrogenase in cancer cells, Int. J. Cell Biol. 2012 (2012) 273947.
[65] M. Board, S. Humm, E.A. Newsholme, Maximum activities of key enzymes of gly-
colysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in
normal, neoplastic and suppressed cells, Biochem. J. 265 (1990) 503–509.
[66] K.A. Brand, U. Hermﬁsse, Aerobic glycolysis by proliferating cells: a protective
strategy against reactive oxygen species, Faseb J. 11 (1997) 388–395.
[67] S. Chakravarthi, C.E. Jessop, N.J. Bulleid, The role of glutathione in disulphide
bond formation and endoplasmic-reticulum-generated oxidative stress, EMBO Rep.
7 (2006) 271–275.
[68] D. von Heimburg, K. Hemmrich, S. Zachariah, H. Staiger, N. Pallua, Oxygen con-
sumption in undiﬀerentiated versus diﬀerentiated adipogenic mesenchymal pre-
cursor cells, Respir. Physiol. Neurobiol. 146 (2005) 107–116.
[69] T. Wallimann, W. Hemmer, Creatine kinase in non-muscle tissues and cells, Mol.
Cell. Biochem. 133–134 (1994) 193–220.
[70] D. Chasiotis, K. Sahlin, E. Hultman, Regulation of glycogenolysis in human muscle
at rest and during exercise, J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 53
(1982) 708–715.
[71] V.A. Saks, A.V. Kuznetsov, V.V. Kupriyanov, M.V. Miceli, W.E. Jacobus, Creatine
kinase of rat heart mitochondria. The demonstration of functional coupling to
oxidative phosphorylation in an inner membrane-matrix preparation, J. Biol. Chem.
260 (1985) 7757–7764.
[72] U. Schlattner, N. Mockli, O. Speer, S. Werner, T. Wallimann, Creatine kinase and
creatine transporter in normal, wounded, and diseased skin, J. Invest. Dermatol.
118 (2002) 416–423.
J. Meyer et al. Experimental Cell Research 370 (2018) 632–642
642
Energy metabolic phenotype of adMSC 
1 
 
Supplementary material 
 
 
Supplementary Fig. S1. Quantification of adMSC metabolic activity in non-stimulated 
cultures (US), osteogenically stimulated cultures (OS) and adipogenically stimulated cultures 
(AS). Cell number after 7 and 21 d (US, OS, AS, n = 4, * significantly different from US 7 d and 
US 21 d respectively; Mann-Whitney U-Test, p < 0.05). 
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Supplementary Fig. S2.: gene expression levels in non-differentiating at 0 d of the 
experimentation period. Related to Figure 3 - (A) LDH isoforms LDHA and LDHB, (B) IDH 
isoforms IDH1, IDH2 and IDH3A, (C) CK isoforms CKB, CKMT1B and CKMT2 (n = 3, * indicate 
significant differences, level of significance: p ≤ 0.05).  
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Supplementary Table S1: Enzyme activities in mitochondrial homogenates vs. whole cell 
homogenates. Related to Figure 4 - Activities of GAPDH and HOADH and HOADH/GAPDH 
ratios in whole cell homogenates (n = 8, U/mg DNA, after 21 d) and mitochondria isolate 
homogenates (n = 4, U/mg protein 14 d culture) from non-differentiating (US), and 
osteogenic (OS) or adipogenic (AS) cultures. 
 
  adMSC   mitochondria  
 US OS AS US OS AS 
HOADH 0.58 2.58 4.09 0.13 0.28 0.40 
GAPDH 75.1 100.7 19.9 0.07 0.10 0.09 
HOADH/ 
GAPDH 
0.01 0.03 0.23 1.67 2.95 5.29 
 
 
 
